Podcasts about melinda gates foundation

The Bill & Melinda Gates Foundation is the epicenter of evil in our modern world, with every Globalist agenda and ideology finding a home, and most importantly, money. With over $55 billion under management, the Gates Foundation has the ability to remake society in its image through its ability to deploy capital to institutions that are actively involved in depopulation and forming a world government. Most people have no idea who Bill Gates actually is and what he stands for because his investments in the media make sure that the truth stays hidden away from the rest of the world. The number of resources that he has provided to organizations that actively kill children with their products should land him in prison for the rest of his life or worse. Let's get real about who Bill Gates actually is, and what his plan for the world entails. The Octopus of Global Control Audiobook: https://amzn.to/3xu0rMm Hypocrazy Audiobook: https://amzn.to/4aogwms Website: www.Macroaggressions.io Activist Post: www.activistpost.com Sponsors: Chemical Free Body: https://www.chemicalfreebody.com Promo Code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO ECI Development: https://info.ecidevelopment.com/-get-to-know-us/macro-aggressions Christian Yordanov's Health Program: www.livelongerformula.com/macro Privacy Academy: https://privacyacademy.com/step/privacy-action-plan-checkout-2/?ref=5620 Brain Supreme: www.BrainSupreme.co Promo Code: MACRO Above Phone: abovephone.com/macro Promo Code: MACRO Van Man: https://vanman.shop/?ref=MACRO Promo Code: MACRO My Patriot Supply: www.PrepareWithMacroaggressions.com Activist Post: www.ActivistPost.com Natural Blaze: www.NaturalBlaze.com Link Tree: https://linktr.ee/macroaggressionspodcast

Building resilient nonprofit teams has never been more crucial. Today I'm bringing you an enlightening conversation recorded LIVE at LinkedIn's 2025 Nonprofit Talent Impact Summit in D.C.You'll hear from Betsy DiMalanta from the Bill & Melinda Gates Foundation and Dr. Luisa Boyarski from Georgetown University's Center for Public and Nonprofit Leadership about what it actually takes to develop effective teams that can weather uncertainty and how to navigate today's complex talent environment. If you're a nonprofit leader, you'll walk away with fresh ideas on hiring, retaining, and developing talent in the world of AI. Plus, you'll hear Betsy and Luisa's three critical pillars for leading through change: communication, co-creation that empowers team members, and clarity around mission.Listen now to transform how your organization can approach talent development in uncertain times and don't miss the 2025 LinkedIn Nonprofit Talent Report.Resources & LinksConnect with Betsy DiMalanta and Dr. Luisa Boyarski on LinkedIn and check out the 2025 LinkedIn Nonprofit Talent Report.Learn more about Georgetown University's Center for Public and Nonprofit Leadership and download their AI Readiness Toolkit for Nonprofits. This show is presented by LinkedIn for Nonprofits. We're so grateful for their partnership. Explore their incredible suite of resources and discounts for nonprofit teams here. Are you still dreaming about building your monthly giving program or refreshing your current one? Applications are now open for my “done with you” Monthly Giving Mastermind. Limited spots are left and we start in July. Click here to apply. My book, The Monthly Giving Mastermind, is here! Grab a copy here and learn my framework to build, grow, and sustain subscriptions for good.Let's Connect! Send a DM on Instagram or LinkedIn and let us know what you think of the show! Head to YouTube for digital marketing how-to videos and podcast teasers Want to book Dana as a speaker for your event? Click here!

The boys cover the biggest news stories of the month of May - Robert Francis Prevost Elected as Pope Leo XIV, Becomes First American PopeFollowing the death of Pope Francis on April 21, 2025, the College of Cardinals elected Cardinal Robert Francis Prevost of Chicago as the new pope. Now Pope Leo XIV, Prevost becomes the first American to ever lead the Roman Catholic Church. Known for his work in Peru and his leadership within the Vatican, Leo XIV signaled a continuation of Francis's legacy with a message of peace and inclusiveness.Pam Bondi Reveals FBI Reviewing 'Tens of Thousands' of Epstein VideosIn a stunning revelation, U.S. Attorney General Pam Bondi stated that the FBI is in possession of “tens of thousands” of videos related to Jeffrey Epstein—many allegedly involving minors. The announcement came after undercover footage captured Bondi casually discussing the investigation. The volume of evidence has raised questions about the pace and transparency of the Epstein probe.James O'Keefe Releases Undercover Video of Pam BondiIndependent journalist James O'Keefe released a covert video showing Pam Bondi speaking about the extensive Epstein video archive. The footage, filmed secretly at a D.C. restaurant, triggered a media firestorm and reignited concerns about elite protection and secrecy in the Epstein case. Bondi later publicly confirmed her comments, insisting the FBI must protect the identities of potential victims.Massive Power Outage Hits Spain and PortugalA major blackout swept across the Iberian Peninsula, leaving millions in Spain and Portugal without electricity. From Madrid to Lisbon, vital infrastructure was crippled—trains stopped, telecoms failed, and hospitals shifted to emergency power. Though services were restored within hours, officials are still investigating possible causes, including a cyberattack or a cascading grid failure.Kanye West's 'Hitler' Song Pulled After OutrageKanye West once again ignited controversy with the release of his new track, “Hitler,” featuring Nazi glorification and racial slurs. The song included a Hitler speech sample and disturbing imagery in its video. Following swift backlash, streaming platforms pulled the track. West claimed censorship, but critics called it another step in a disturbing pattern.Bill Gates to Donate Entire Fortune, Shutter Foundation by 2045Bill Gates pledged to give away nearly all of his $200 billion fortune to global health causes, with plans to close the Bill & Melinda Gates Foundation by 2045. He aims to double annual spending to fight disease, poverty, and maternal mortality, urging fellow billionaires to act now in the face of rising global crises.UK and US Sign Trade Deal, Slash TariffsThe U.S. and U.K. signed a new trade agreement that slashes tariffs on cars, steel, and agriculture products. While it doesn't resolve all trade issues, officials see it as a vital step in strengthening transatlantic economic ties.Katy Perry Blasts Off on All-Female Space MissionPop icon Katy Perry joined the first all-female Blue Origin spaceflight, journeying beyond the Kármán line in a historic suborbital mission. Joined by journalist Gayle King and others, Perry called the trip “supernatural” and dedicated the experience to her daughter.Ben & Jerry's Co-Founder Arrested at Senate ProtestBen Cohen, co-founder of Ben & Jerry's, was arrested for protesting during a Senate hearing, calling out U.S. involvement in Gaza. He faces charges for obstruction after criticizing lawmakers for prioritizing military funding over humanitarian aid. His arrest reignited debate over activism and U.S. foreign policy.www.patreon.com/theconspiracypodcast

About the GuestMelanie Wendland is a pioneering design strategist with over 18 years of experience in service design and a decade applying design to global health challenges. Specialising in reproductive, maternal, newborn, and child health, she combines design, behavioural science, and data to drive better decision-making and social impact. As co-founder of Sonder Collective, where she led as chairwoman until 2022, Melanie has spearheaded innovative approaches to tackle complex global health issues.Currently pursuing a PhD in Health Sciences, Melanie is a sought-after advisor, mentor, speaker, and lecturer on service design and social innovation. She has collaborated with world-leading organisations, including The Bill & Melinda Gates Foundation, WHO, and Merck for Mothers, to create transformative change in global health.This Episode CoversExploring Alternative Business Models: Businesses can operate beyond traditional hierarchies by adopting models like cooperatives, which emphasise shared ownership, democratic decision-making, and reinvesting profits back into the organisation to create sustainable and inclusive structures.The Role of Human-Centered Design: Human-centered design is a problem-solving approach that focuses on understanding the needs and experiences of people. By collecting insights, creating prototypes, and refining solutions, organisations can develop products and services that are effective, relevant, and meaningful.Addressing Complex Challenges Through Research and Design: Combining thorough research with thoughtful design can help solve large-scale societal issues. For example, blending qualitative interviews and quantitative data can inform strategies that directly address community needs or systemic problems like public health challenges.Decentralised Leadership and Decision-Making: Decentralised organisations demonstrate that leadership doesn't always require traditional hierarchies. By distributing roles and responsibilities based on expertise rather than position, these systems allow teams to operate flexibly while maintaining transparency and collaboration.Practical Strategies for Business Innovation: Gathering feedback from users or customers and analysing it effectively is crucial for innovation. Businesses can improve their offerings and customer experience by using structured processes to build solutions that reflect real-world needs.Integrating Structure and Creativity for Success: Effective organisations find a balance between creative freedom and structured systems. Clear processes for decision-making, transparent communication, and feedback systems enable teams to operate efficiently while fostering innovation and collaboration.LinksWebsite: Sonder CollectiveSocial media: Linkedin

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, biotech innovation, and global health leadership. In this episode, Susan shares insights from her journey training in internal medicine during the early AIDS crisis, treating HIV-related cancers in Uganda, and developing groundbreaking cancer therapies like Herceptin and Avastin. She reflects on her leadership roles at UCSF and the Bill and Melinda Gates Foundation, offering lessons on guiding large-scale health initiatives, navigating uncertainty, and fostering scientific innovation. The conversation explores the promise of precision medicine, the integration of patient care and policy, and the evolving role of artificial intelligence in transforming diagnostics, drug development, and global access to care. We discuss: Susan's medical training, the start of the AIDS epidemic, and the transformative experiences that shaped her career [3:00]; Susan's experience working on the frontlines of the HIV/AIDS crisis in Uganda [12:30]; Susan's time working in general oncology and her transition to biotech where she helped develop taxol—a top-selling cancer drug [26:30]; Genentech's origins, and its groundbreaking use of recombinant DNA to develop biologic drugs [33:45]; Susan's move to Genentech, and her pivotal role in the development and success of Herceptin as a groundbreaking therapy in targeted oncology [44:00]; The rise of antibody-based cancer therapies: the development of Rituxan and Avastin [52:15]; The step-by-step drug development process and the scientific and strategic challenges involved [1:01:30]; The ethical and economic controversy surrounding Avastin's high cost and limited survival benefit [1:12:30]; Susan's tenure as chancellor at UCSF: leading during a financially strained period, and her strategic approach to fundraising and institutional development [1:14:45]; What Susan learned as CEO of the Bill and Melinda Gates Foundation: strategic processes and decision-making frameworks [1:26:00]; Susan's philosophy of leadership and how she sought to build an empowering, values-driven culture at the Gates Foundation [1:35:15]; The erosion of public trust in science during COVID, the communication failures around controversial treatments like ivermectin, and the need for better public health engagement and transparency [1:39:30]; The role of AI in transforming medicine: from drug development to cancer detection and beyond [1:53:00]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Listen to those three questions again - Can I Succeed? Do I Belong? Am I Loved? I'm tempted to feel those questions address the root issue of every human on earth. As I continue to research personal identity and how we as a culture seem to be more fragile and threatened than ever, I feel these questions are primary. So I had a conversation with Dr Gregory Walton. Greg is the co-director of the Dweck-Walton Labs. Dweck as in Carol Dweck, the legend of mindset. Greg is also a professor of psychology at Stanford. Much of Greg's research investigates psychological processes that contribute to major social problems. His research is supported by many foundations, including the Bill and Melinda Gates Foundation. As weighty as all this sounds, Greg's quest is to discover simple psychological shifts that build trust, belonging, and confidence. He's culminated his findings in a new book, titled Ordinary Magic: The Science of How We Can Achieve Big Change with Small Acts. So can addressing these huge questions be so simple? What I came to as we talked, was, yes, the answers can be simple, because they cut to the root cause issues of ourselves. But. I don't call them easy. Not at all. At the top of the show I pull this quote out from Greg, “An hour-long surgery can change your life forever. Is there any reason a precise psychological exercise can't do the same?” But going under the knife is a big decision. So is choosing to believe differently than you have. Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

Zanele Abraham Matome, the visionary founder of Welo Health — a platform revolutionizing healthcare access across South Africa and the SADC region.From growing up in communities with limited healthcare, to building a nationwide gig-economy model connecting nurses, doctors, and patients, Zanele shares her remarkable journey of purpose, innovation, and resilience.We dive into her early lessons as a mining contractor, her bold pivot into healthtech, and the mindset shifts that helped her transform personal experiences into a scalable solution recognized by global institutions like the Bill & Melinda Gates Foundation.Zanele also unpacks the key differences between building a startup in South Africa versus Silicon Valley, the real challenges founders face on the continent, and what it takes to create impactful ventures that blend human touch and technology.

On this episode of The Songwriter Connection, we welcome the extraordinary Tai Shan—a Nashville singer-songwriter whose music has been featured in Billboard Magazine, American Songwriter, and NPR. Having toured across the U.S., Mexico, and Canada, Tai has performed for audiences as prestigious as the Bill & Melinda Gates Foundation—and even the Pope!Join us as Tai takes us on a journey through her incredible experiences on the road, the stories behind her songs, and the lessons she's learned along the way. We'll also dive into her 20-minute rule—a unique approach to songwriting that keeps creativity flowing. And of course, no episode would be complete without some live music around the dining room table!Don't miss this inspiring and insightful conversation with one of Nashville's most dynamic voices.Support this podcast at — https://redcircle.com/songwriter-connection/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On this episode of 1050 Bascom, we were honored to welcome Ambassador John E. Lange, a distinguished diplomat, global health leader, and proud alumni of the University of Wisconsin-Madison. Over his 28-year career in the U.S. Foreign Service, Ambassador Lange served in pivotal roles, including U.S. Ambassador to Botswana, Special Representative on Avian and Pandemic Influenza, and Deputy U.S. Global AIDS Coordinator at the launch of the President's Emergency Plan for AIDS Relief.His career has taken him from high-level diplomatic negotiations to frontline crisis leadership. After retiring from the Foreign Service in 2009, Ambassador Lange continued his commitment to global health at the Bill & Melinda Gates Foundation and the United Nations Foundation, where he has worked to advance global health diplomacy, pandemic preparedness, and disease eradication initiatives.In this episode, Ambassador Lange shared insights from his diplomatic career, his work in global health, and the importance of public service in addressing global challenges. We thoroughly enjoyed our conversation with Ambassador Lange and learned so much. We hope you will too.

Send us a textTom Vander Ark is an advocate for innovations in learning. As CEO of Getting Smart, he advises schools, districts, networks, foundations, and learning organizations on the path forward. Tom is the author of Getting Smart, Smart Cities That Work for Everyone, Smart Parents, Better Together, The Power of Place, and Difference Making at the Heart of Learning. He has published thousands of articles and papers through GettingSmart.com and LinkedIn.Previously he launched one of the first edtech venture funds, was president of the X-Prize Foundation, served as the first Executive Director of Education for the Bill & Melinda Gates Foundation. Tom served as a public school superintendent in Washington State and has extensive private sector experience. He serves on the board of Digital Learning Institute, Latinx Education Collaborative, Mastery Transcript Consortium, and Getting Smart Collective and advises schools, impact organizations and edtech startups.

In this episode, we talk to Melinda French Gates. Famous as one half of the Bill & Melinda Gates Foundation – one of the largest philanthropic outfits in the world – Melinda spent more than two decades overseeing the giving-away of more than $US77 billion. Then, in 2021, she and Bill divorced after 27 years of marriage, and Melinda began to chart a new path for her life. That new path is the subject of a feature profile in this week's magazine – "The 'Gigantic Joy' of a Fresh Start" – in which Gates discusses the end of her marriage, the hard-won pleasures of personal growth, and philanthropy in Trump's America. She joins us today to chat about all that and more, with Good Weekend senior writer, Amanda Hooton. See omnystudio.com/listener for privacy information.

Liz is joined by Nada Hanafi to talk all things clinical trials. They start by defining the clinical trial pathways and all the acronyms used. Then, they discuss how training can be used as a mitigation measure for avoiding risk, exploring the benefits and drawbacks for this approach and how the strategy can be modified along the process. Learn more about the process and how the answer is often "it depends."In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Related Resources:Nada Hanafi is a thought leader within the Life Sciences and MedTech industry with over 22 years of experience across the public and private sectors. She is a Founder of MedTech Strategy Advisors, LLC where she advises life science companies on regulatory strategy, product development, and clinical research to accomplish regulatory, compliance, and business goals.Nada spent over 12.5 years working for the FDA, serving in increasing roles of responsibility and ultimately as a Senior Science Health Advisor in the Center for Devices and Radiological Health (CDRH), where she led cross - Center and Agency programs for the advancement of FDA's mission to promote and protect public health, including as Co-Founder of the Health of Women (HoW) program, the Network of Experts program and the Patient Preference Initiative. She served as CDRH Liaison and Subject Matter Expert to FDs's Office of Women's Health (OWH) and the Office of Minority Health and Health Equity (OMHHE). She collaborated with the Center for Tobacco (CTP) and the National Institutes of Health (NIH) where she served as Senior Management Advisor to the Director at the Office of Research on Women's Health (ORWH), to improve regulatory efficiency and to strengthen data collection. Nada's drive and passion to address health inequities with a focus on women and minorities led her to Co-Found MedTech Color, a non-profit focused on advancing the representation of people of color within MedTech. Nada also serves on the Steering Committee and as Co-Lead on the Regulatory and Science Policy subcommittee for the Innovation Equity Forum (IEF) led by the NIH's ORWH and the Bill and Melinda Gates Foundation.Nada holds an MSc in Biomaterials and a BEng in Biomedical Materials Science & Engineering from Queen Mary College, University of London. She earned her MPH from Johns Hopkins Bloomberg School of Public Health. Nada is a Certified Quality Improvement Associate (CQIA) and a Certified Quality Auditor (CQA) from the American Society for Quality (ASQ).Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe!Connect with us on LinkedIn:   ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nada Hanafi⁠⁠⁠⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠About Cumby Consulting:   Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Send us a textDr. Marianne Holm, MD, Ph.D. is Vice President of the Infectious Diseases Program area, at the Novo Nordisk Foundation ( https://novonordiskfonden.dk/en/ ) where she is responsible for supporting the development and implementation of new strategic initiatives and research programs, and developing partnerships that contribute to the global visibility and impact of the foundation's activities within Infectious Diseases, and this responsibility includes supporting multiple cross disciplinary initiatives in Antimicrobial Resistance (AMR).Dr. Holm is a medical doctor and epidemiologist, who previously led the department of epidemiology and public health research at the International Vaccine Institute (IVI) in Seoul, where she was responsible for the coordination and implementation of several large development programs funded by the Fleming Fund, working with local governments and healthcare institutions to build capacity in AMR surveillance in low- and middle- income countries in the Asian region. Prior to joining IVI in 2018, Dr. Holm worked for 4 years at the School of Public Health at the University of Hong Kong working in the health services research unit coordinating the School's evidence based practice education program.Dr. Holm has been a member of the coordination group of the WHO Technical Advisory Group and Coordination Group on Vaccines and AMR. She is also a member of the Global Burden of Disease (GBD) Collaborator Network as well as the Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC) network.Dr. Holm received her MD and Ph.D. from University of Copenhagen and Master of Science (MSc), Epidemiology, London School of Hygiene and Tropical Medicine, U. of London.IMPORTANT EPISODE LINK - Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) - https://gcgh.grandchallenges.org/challenge/innovations-gram-negative-antibiotic-discovery The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) is tripartite initiative of the Novo Nordisk Foundation, the Bill & Melinda Gates Foundation and Wellcome Trust, that will focus on discovery of direct-acting small-molecule antibiotics with broad-spectrum activity against Enterobacteriaceae (a large family of Gram-negative bacteria that includes Salmonella, Escherichia coli, Shigella and Klebsiella), with Klebsiella spp. selected as an initial targeted pathogen. Klebsiella organisms can lead to a wide range of disease states, notably pneumonia, urinary tract infections, sepsis, meningitis, diarrhea, peritonitis and soft tissue infections. The program aims to address the lack of novel antibiotics for gram-negative bacteria and the public health threat posed by antimicrobial resistance (AMR).#NovoNordiskFoundation #GramNegativeAntibioticDiscoveryInnovator #BillAndMelindaGatesFoundation #WellcomeTrust #AMR #AntimicrobialResistance #Enterobacteriaceae #Klebsiella #Salmonella #EscherichiaColi #Shigella #InfectiousDiseases #MarianneHolm #Vaccines #MultidrugEffluxPumps #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

How to achieve BIG change with small acts? According to the Stanford psychologist Gregory Walton, this requires what, in his new book, he dubs Ordinary Magic. Small psychological interventions , Walton argues, can create significant positive changes. He explains that people often face "agency-depriving questions" that undermine their confidence and sense of belonging. His research shows how addressing these concerns through simple but powerful psychological reframes and supportive interactions can help individuals overcome obstacles. Walton distinguishes his evidence-based approach from typical self-help books and "nudge" tactics, emphasizing that while these interventions may appear simple, they require careful design based on deep understanding of human psychology.Here are the five KEEN ON AMERICA takeaways from our conversation with Walton:* "Ordinary magic" refers to everyday experiences that help people overcome limiting self-doubts, creating potential for extraordinary positive change.* People often face psychological barriers in the form of questions like "Can I do it?" "Do I belong?" and "Does this matter?" which can become self-fulfilling prophecies.* Unlike behavorial economics style "nudge" approaches that treat people like objects to be manipulated, Walton's interventions aim to help people understand and reframe how they make sense of challenging situations.* Simple psychological reframes (like telling a tired child "when you're tired and keep going, your muscles get stronger") can have profound effects on persistence and achievement.* Creating environments where people feel they belong and are valued can dramatically improve outcomes - as demonstrated by interventions that reduced juvenile recidivism from 69% to 29% by connecting students with supportive teachers.* Greg Walton, PhD, is the co-director of the Dweck-Walton Lab and a professor of psychology at Stanford University. Dr. Walton's research is supported by many foundations, including Character Lab, the Bill and Melinda Gates Foundation, and the William and Flora Hewlett Foundation. He has been covered in major media outlets including The New York Times, Harvard Business Review, The Wall Street Journal, NPR, The Chronicle of Higher Education, The Washington Post, San Francisco Chronicle, and Los Angeles Times.Named as one of the "100 most connected men" by GQ magazine, Andrew Keen is amongst the world's best known broadcasters and commentators. In addition to presenting the daily KEEN ON show, he is the host of the long-running How To Fix Democracy interview series. He is also the author of four prescient books about digital technology: CULT OF THE AMATEUR, DIGITAL VERTIGO, THE INTERNET IS NOT THE ANSWER and HOW TO FIX THE FUTURE. Andrew lives in San Francisco, is married to Cassandra Knight, Google's VP of Litigation & Discovery, and has two grown children.Keen On America is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit keenon.substack.com/subscribe

Harnessing Synthetic Biology for Sustainable Mining and Pollution Mitigation.In this episode of The Greener Way, guest host Michelle Baltazar interviews Nicole Richards, CEO of Allonnia, about the company's use of synthetic biology to address sustainability issues. The discussion covers Allonia's work in accelerating nature's process of breaking down contaminants like PFAS, and their initiatives in the mining sector to reduce waste and greenhouse gas emissions. The episode highlights Allonnia's partnerships in Australia, significant investors including BHP, Vale, and the Bill and Melinda Gates Foundation, and the company's aim to commercialise these technologies.This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

Request Access to the FREE Health Impact SoftwareClick this link. ⁠FREE Health Impact APP⁠No strings attached—we will send an email, and you'll receive an exclusive download link.Take Action:

Dr. Gary Null provides a commentary on "Universal  Healthcare"       Universal Healthcare is the Solution to a Broken Medical System Gary Null, PhD Progressive Radio Network, March 3, 2025 For over 50 years, there has been no concerted or successful effort to bring down medical costs in the American healthcare system. Nor are the federal health agencies making disease prevention a priority. Regardless whether the political left or right sponsors proposals for reform, such measures are repeatedly defeated by both parties in Congress. As a result, the nation's healthcare system remains one of the most expensive and least efficient in the developed world. For the past 30 years, medical bills contributing to personal debt regularly rank among the top three causes of personal bankruptcy. This is a reality that reflects not only the financial strain on ordinary Americans but the systemic failure of the healthcare system itself. The urgent question is: If President Trump and his administration are truly seeking to reduce the nation's $36 trillion deficit, why is there no serious effort to reform the most bloated and corrupt sector of the economy? A key obstacle is the widespread misinformation campaign that falsely claims universal health care would cost an additional $2 trillion annually and further balloon the national debt. However, a more honest assessment reveals the opposite. If the US adopted a universal single-payer system, the nation could actually save up to $20 trillion over the next 10 years rather than add to the deficit. Even with the most ambitious efforts by people like Elon Musk to rein in federal spending or optimize government efficiency, the estimated savings would only amount to $500 billion. This is only a fraction of what could be achieved through comprehensive healthcare reform alone. Healthcare is the largest single expenditure of the federal budget. A careful examination of where the $5 trillion spent annually on healthcare actually goes reveals massive systemic fraud and inefficiency. Aside from emergency medicine, which accounts for only 10-12 percent of total healthcare expenditures, the bulk of this spending does not deliver better health outcomes nor reduce trends in physical and mental illness. Applying Ockham's Razor, the principle that the simplest solution is often the best, the obvious conclusion is that America's astronomical healthcare costs are the direct result of price gouging on an unimaginable scale. For example, in most small businesses, profit margins range between 1.6 and 2.5 percent, such as in grocery retail. Yet the pharmaceutical industrial complex routinely operates on markup rates as high as 150,000 percent for many prescription drugs. The chart below highlights the astronomical gap between the retail price of some top-selling patented pharmaceutical medications and their generic equivalents. Drug Condition Patent Price (per unit) Generic Price Estimated Manufacture Cost Markup Source Insulin (Humalog) Diabetes $300 $30 $3 10,000% Rand (2021) EpiPen Allergic reactions $600 $30 $10 6,000% BMJ (2022) Daraprim Toxoplasmosis $750/pill $2 $0.50 150,000% JAMA (2019) Harvoni Hepatitis C $94,500 (12 weeks) $30,000 $200 47,000% WHO Report (2018) Lipitor Cholesterol $150 $10 $0.50 29,900% Health Affairs (2020) Xarelto Blood Thinner $450 $25 $1.50 30,000% NEJM (2020) Abilify Schizophrenia $800 (30 tablets) $15 $2 39,900% AJMC (2019) Revlimid Cancer $16,000/mo $450 $150 10,500% Kaiser Health News (2021) Humira Arthritis $2,984/dose $400 $50 5,868% Rand (2021) Sovaldi Hepatitis C $1,000/pill $10 $2 49,900% JAMA (2021) Xolair Asthma $2,400/dose $300 $50 4,800% NEJM (2020) Gleevec Leukemia $10,000/mo $350 $200 4,900% Harvard Public Health Review (2020) OxyContin Pain Relief $600 (30 tablets) $15 $0.50 119,900% BMJ (2022) Remdesivir Covid-19 $3,120 (5 doses) N/A $10 31,100% The Lancet (2020) The corruption extends far beyond price gouging. Many pharmaceutical companies convince federal health agencies to fund their basic research and drug development with taxpayer dollars. Yet when these companies bring successful products to market, the profits are kept entirely by the corporations or shared with the agencies or groups of government scientists. On the other hand, the public, who funded the research, receives no financial return. This amounts to a systemic betrayal of the public trust on a scale of hundreds of billions of dollars annually. Another significant contributor to rising healthcare costs is the widespread practice of defensive medicine that is driven by the constant threat of litigation. Over the past 40 years, defensive medicine has become a cottage industry. Physicians order excessive diagnostic tests and unnecessary treatments simply to protect themselves from lawsuits. Study after study has shown that these over-performed procedures not only inflate costs but lead to iatrogenesis or medical injury and death caused by the medical  system and practices itself. The solution is simple: adopting no-fault healthcare coverage for everyone where patients receive care without needing to sue and thereby freeing doctors from the burden of excessive malpractice insurance. A single-payer universal healthcare system could fundamentally transform the entire industry by capping profits at every level — from drug manufacturers to hospitals to medical equipment suppliers. The Department of Health and Human Services would have the authority to set profit margins for medical procedures. This would ensure that healthcare is determined by outcomes, not profits. Additionally, the growing influence of private equity firms and vulture capitalists buying up hospitals and medical clinics across America must be reined in. These equity firms prioritize profit extraction over improving the quality of care. They often slash staff, raise prices, and dictate medical procedures based on what will yield the highest returns. Another vital reform would be to provide free medical education for doctors and nurses in exchange for five years of service under the universal system. Medical professionals would earn a realistic salary cap to prevent them from being lured into equity partnerships or charging exorbitant rates. The biggest single expense in the current system, however, is the private health insurance industry, which consumes 33 percent of the $5 trillion healthcare budget. Health insurance CEOs consistently rank among the highest-paid executives in the country. Their companies, who are nothing more than bean counters, decide what procedures and drugs will be covered, partially covered, or denied altogether. This entire industry is designed to place profits above patients' lives. If the US dismantled its existing insurance-based system and replaced it with a fully reformed national healthcare model, the country could save $2.7 trillion annually while simultaneously improving health outcomes. Over the course of 10 years, those savings would amount to $27 trillion. This could wipe out nearly the entire national debt in a short time. This solution has been available for decades but has been systematically blocked by corporate lobbying and bipartisan corruption in Washington. The path forward is clear but only if American citizens demand a system where healthcare is valued as a public service and not a commodity. The national healthcare crisis is not just a fiscal issue. It is a crucial moral failure of the highest order. With the right reforms, the nation could simultaneously restore its financial health and deliver the kind of healthcare system its citizens have long deserved. American Healthcare: Corrupt, Broken and Lethal Richard Gale and Gary Null Progressive Radio Network, March 3, 2025 For a nation that prides itself on being the world's wealthiest, most innovative and technologically advanced, the US' healthcare system is nothing less than a disaster and disgrace. Not only are Americans the least healthy among the most developed nations, but the US' health system ranks dead last among high-income countries. Despite rising costs and our unshakeable faith in American medical exceptionalism, average life expectancy in the US has remained lower than other OECD nations for many years and continues to decline. The United Nations recognizes healthcare as a human right. In 2018, former UN Secretary General Ban Ki-moon denounced the American healthcare system as "politically and morally wrong." During the pandemic it is estimated that two to three years was lost on average life expectancy. On the other hand, before the Covid-19 pandemic, countries with universal healthcare coverage found their average life expectancy stable or slowly increasing. The fundamental problem in the U.S. is that politics have been far too beholden to the pharmaceutical, HMO and private insurance industries. Neither party has made any concerted effort to reign in the corruption of corporate campaign funding and do what is sensible, financially feasible and morally correct to improve Americans' quality of health and well-being.   The fact that our healthcare system is horribly broken is proof that moneyed interests have become so powerful to keep single-payer debate out of the media spotlight and censored. Poll after poll shows that the American public favors the expansion of public health coverage. Other incremental proposals, including Medicare and Medicaid buy-in plans, are also widely preferred to the Affordable Care Act or Obamacare mess we are currently stuck with.   It is not difficult to understand how the dismal state of American medicine is the result of a system that has been sold out to the free-market and the bottom line interests of drug makers and an inflated private insurance industry. How advanced and ethically sound can a healthcare system be if tens of millions of people have no access to medical care because it is financially out of their reach?  The figures speak for themselves. The U.S. is burdened with a $41 trillion Medicare liability. The number of uninsured has declined during the past several years but still lingers around 25 million. An additional 30-35 million are underinsured. There are currently 65 million Medicare enrollees and 89 million Medicaid recipients. This is an extremely unhealthy snapshot of the country's ability to provide affordable healthcare and it is certainly unsustainable. The system is a public economic failure, benefiting no one except the large and increasingly consolidated insurance and pharmaceutical firms at the top that supervise the racket.   Our political parties have wrestled with single-payer or universal healthcare for decades. Obama ran his first 2008 presidential campaign on a single-payer platform. Since 1985, his campaign health adviser, the late Dr. Quentin Young from the University of Illinois Medical School, was one of the nation's leading voices calling for universal health coverage.  During a private conversation with Dr. Young shortly before his passing in 2016, he conveyed his sense of betrayal at the hands of the Obama administration. Dr. Young was in his 80s when he joined the Obama campaign team to help lead the young Senator to victory on a promise that America would finally catch up with other nations. The doctor sounded defeated. He shared how he was manipulated, and that Obama held no sincere intention to make universal healthcare a part of his administration's agenda. During the closed-door negotiations, which spawned the weak and compromised Affordable Care Act, Dr. Young was neither consulted nor invited to participate. In fact, he told us that he never heard from Obama again after his White House victory.   Past efforts to even raise the issue have been viciously attacked. A huge army of private interests is determined to keep the public enslaved to private insurers and high medical costs. The failure of our healthcare is in no small measure due to it being a fully for-profit operation. Last year, private health insurance accounted for 65 percent of coverage. Consider that there are over 900 private insurance companies in the US. National Health Expenditures (NHE) grew to $4.5 trillion in 2022, which was 17.3 percent of GDP. Older corporate rank-and-file Democrats and Republicans argue that a single-payer or socialized medical program is unaffordable. However, not only is single-payer affordable, it will end bankruptcies due to unpayable medical debt. In addition, universal healthcare, structured on a preventative model, will reduce disease rates at the outset.    Corporate Democrats argue that Obama's Affordable Care Act (ACA) was a positive step inching the country towards complete public coverage. However, aside from providing coverage to the poorest of Americans, Obamacare turned into another financial anchor around the necks of millions more. According to the health policy research group KFF, the average annual health insurance premium for single coverage is $8,400 and almost $24,000 for a family. In addition, patient out-of-pocket costs continue to increase, a 6.6% increase to $471 billion in 2022. Rather than healthcare spending falling, it has exploded, and the Trump and Biden administrations made matters worse.    Clearly, a universal healthcare program will require flipping the script on the entire private insurance industry, which employed over half a million people last year.  Obviously, the most volatile debate concerning a national universal healthcare system concerns cost. Although there is already a socialized healthcare system in place -- every federal legislator, bureaucrat, government employee and veteran benefits from it -- fiscal Republican conservatives and groups such as the Koch Brothers network are single-mindedly dedicated to preventing the expansion of Medicare and Medicaid. A Koch-funded Mercatus analysis made the outrageous claim that a single-payer system would increase federal health spending by $32 trillion in ten years. However, analyses and reviews by the Congressional Budget Office in the early 1990s concluded that such a system would only increase spending at the start; enormous savings would quickly offset it as the years pass. In one analysis, "the savings in administrative costs [10 percent of health spending] would be more than enough to offset the expense of universal coverage."    Defenders of those advocating for funding a National Health Program argue this can primarily be accomplished by raising taxes to levels comparable to other developed nations. This was a platform Senator Bernie Sanders and some of the younger progressive Democrats in the House campaigned on. The strategy was to tax the highest multimillion-dollar earners 60-70 percent. Despite the outrage of its critics, including old rank-and-file multi-millionaire Democrats like Nancy Pelosi and Chuck Schumer, this is still far less than in the past. During the Korean War, the top tax rate was 91 percent; it declined to 70 percent in the late 1960s. Throughout most of the 1970s, those in the lowest income bracket were taxed at 14 percent. We are not advocating for this strategy because it ignores where the funding is going, and the corruption in the system that is contributing to exorbitant waste.    But Democratic supporters of the ACA who oppose a universal healthcare plan ignore the additional taxes Obama levied to pay for the program. These included surtaxes on investment income, Medicare taxes from those earning over $200,000, taxes on tanning services, an excise tax on medical equipment, and a 40 percent tax on health coverage for costs over the designated cap that applied to flexible savings and health savings accounts. The entire ACA was reckless, sloppy and unnecessarily complicated from the start.    The fact that Obamacare further strengthened the distinctions between two parallel systems -- federal and private -- with entirely different economic structures created a labyrinth of red tape, rules, and wasteful bureaucracy. Since the ACA went into effect, over 150 new boards, agencies and programs have had to be established to monitor its 2,700 pages of gibberish. A federal single-payer system would easily eliminate this bureaucracy and waste.    A medical New Deal to establish universal healthcare coverage is a decisive step in the correct direction. But we must look at the crisis holistically and in a systematic way. Simply shuffling private insurance into a federal Medicare-for-all or buy-in program, funded by taxing the wealthiest of citizens, would only temporarily reduce costs. It will neither curtail nor slash escalating disease rates e. Any effective healthcare reform must also tackle the underlying reasons for Americans' poor state of health. We cannot shy away from examining the social illnesses infecting our entire free-market capitalist culture and its addiction to deregulation. A viable healthcare model would have to structurally transform how the medical economy operates. Finally, a successful medical New Deal must honestly evaluate the best and most reliable scientific evidence in order to effectively redirect public health spending.    For example, Dr. Ezekiel Emanuel, a former Obama healthcare adviser, observed that AIDS-HIV measures consume the most public health spending, even though the disease "ranked 75th on the list of diseases by personal health expenditures." On the other hand, according to the American Medical Association, a large percentage of the nation's $3.4 trillion healthcare spending goes towards treating preventable diseases, notably diabetes, common forms of heart disease, and back and neck pain conditions. In 2016, these three conditions were the most costly and accounted for approximately $277 billion in spending. Last year, the CDC announced the autism rate is now 1 in 36 children compared to 1 in 44 two years ago. A retracted study by Mark Blaxill, an autism activist at the Holland Center and a friend of the authors, estimates that ASD costs will reach $589 billion annually by 2030. There are no signs that this alarming trend will reverse and decline; and yet, our entire federal health system has failed to conscientiously investigate the underlying causes of this epidemic. All explanations that might interfere with the pharmaceutical industry's unchecked growth, such as over-vaccination, are ignored and viciously discredited without any sound scientific evidence. Therefore, a proper medical New Deal will require a systemic overhaul and reform of our federal health agencies, especially the HHS, CDC and FDA. Only the Robert Kennedy Jr presidential campaign is even addressing the crisis and has an inexpensive and comprehensive plan to deal with it. For any medical revolution to succeed in advancing universal healthcare, the plan must prioritize spending in a manner that serves public health and not private interests. It will also require reshuffling private corporate interests and their lobbyists to the sidelines, away from any strategic planning, in order to break up the private interests' control over federal agencies and its revolving door policies. Aside from those who benefit from this medical corruption, the overwhelming majority of Americans would agree with this criticism. However, there is a complete lack of national trust that our legislators, including the so-called progressives, would be willing to undertake such actions.    In addition, America's healthcare system ignores the single most critical initiative to reduce costs - that is, preventative efforts and programs instead of deregulation and closing loopholes designed to protect the drug and insurance industries' bottom line. Prevention can begin with banning toxic chemicals that are proven health hazards associated with current disease epidemics, and it can begin by removing a 1,000-plus toxins already banned in Europe. This should be a no-brainer for any legislator who cares for public health. For example, Stacy Malkan, co-founder of the Campaign for Safe Cosmetics, notes that "the policy approach in the US and Europe is dramatically different" when it comes to chemical allowances in cosmetic products. Whereas the EU has banned 1,328 toxic substances from the cosmetic industry alone, the US has banned only 11. The US continues to allow carcinogenic formaldehyde, petroleum, forever chemicals, many parabens (an estrogen mimicker and endocrine hormone destroyer), the highly allergenic p-phenylenediamine or PBD, triclosan, which has been associated with the rise in antibiotic resistant bacteria, avobenzone, and many others to be used in cosmetics, sunscreens, shampoo and hair dyes.   Next, the food Americans consume can be reevaluated for its health benefits. There should be no hesitation to tax the unhealthiest foods, such as commercial junk food, sodas and candy relying on high fructose corn syrup, products that contain ingredients proven to be toxic, and meat products laden with dangerous chemicals including growth hormones and antibiotics. The scientific evidence that the average American diet is contributing to rising disease trends is indisputable. We could also implement additional taxes on the public advertising of these demonstrably unhealthy products. All such tax revenue would accrue to a national universal health program to offset medical expenditures associated with the very illnesses linked to these products. Although such tax measures would help pay for a new medical New Deal, it may be combined with programs to educate the public about healthy nutrition if it is to produce a reduction in the most common preventable diseases. In fact, comprehensive nutrition courses in medical schools should be mandatory because the average physician receives no education in this crucial subject.  In addition, preventative health education should be mandatory throughout public school systems.   Private insurers force hospitals, clinics and private physicians into financial corners, and this is contributing to prodigious waste in money and resources. Annually, healthcare spending towards medical liability insurance costs tens of billions of dollars. In particular, this economic burden has taxed small clinics and physicians. It is well past the time that physician liability insurance is replaced with no-fault options. Today's doctors are spending an inordinate amount of money to protect themselves. Legions of liability and trial lawyers seek big paydays for themselves stemming from physician error. This has created a culture of fear among doctors and hospitals, resulting in the overly cautious practice of defensive medicine, driving up costs and insurance premiums just to avoid lawsuits. Doctors are forced to order unnecessary tests and prescribe more medications and medical procedures just to cover their backsides. No-fault insurance is a common-sense plan that enables physicians to pursue their profession in a manner that will reduce iatrogenic injuries and costs. Individual cases requiring additional medical intervention and loss of income would still be compensated. This would generate huge savings.    No other nation suffers from the scourge of excessive drug price gouging like the US. After many years of haggling to lower prices and increase access to generic drugs, only a minute amount of progress has been made in recent years. A 60 Minutes feature about the Affordable Care Act reported an "orgy of lobbying and backroom deals in which just about everyone with a stake in the $3-trillion-a-year health industry came out ahead—except the taxpayers.” For example, Life Extension magazine reported that an antiviral cream (acyclovir), which had lost its patent protection, "was being sold to pharmacies for 7,500% over the active ingredient cost. The active ingredient (acyclovir) costs only 8 pennies, yet pharmacies are paying a generic maker $600 for this drug and selling it to consumers for around $700." Other examples include the antibiotic Doxycycline. The price per pill averages 7 cents to $3.36 but has a 5,300 percent markup when it reaches the consumer. The antidepressant Clomipramine is marked up 3,780 percent, and the anti-hypertensive drug Captopril's mark-up is 2,850 percent. And these are generic drugs!    Medication costs need to be dramatically cut to allow drug manufacturers a reasonable but not obscene profit margin. By capping profits approximately 100 percent above all costs, we would save our system hundreds of billions of dollars. Such a measure would also extirpate the growing corporate misdemeanors of pricing fraud, which forces patients to pay out-of-pocket in order to make up for the costs insurers are unwilling to pay.    Finally, we can acknowledge that our healthcare is fundamentally a despotic rationing system based upon high insurance costs vis-a-vis a toss of the dice to determine where a person sits on the economic ladder. For the past three decades it has contributed to inequality. The present insurance-based economic metrics cast millions of Americans out of coverage because private insurance costs are beyond their means. Uwe Reinhardt, a Princeton University political economist, has called our system "brutal" because it "rations [people] out of the system." He defined rationing as "withholding something from someone that is beneficial." Discriminatory healthcare rationing now affects upwards to 60 million people who have been either priced out of the system or under insured. They make too much to qualify for Medicare under Obamacare, yet earn far too little to afford private insurance costs and premiums. In the final analysis, the entire system is discriminatory and predatory.    However, we must be realistic. Almost every member of Congress has benefited from Big Pharma and private insurance lobbyists. The only way to begin to bring our healthcare program up to the level of a truly developed nation is to remove the drug industry's rampant and unnecessary profiteering from the equation.     How did Fauci memory-hole a cure for AIDS and get away with it?   By Helen Buyniski   Over 700,000 Americans have died of AIDS since 1981, with the disease claiming some 42.3 million victims worldwide. While an HIV diagnosis is no longer considered a certain death sentence, the disease looms large in the public imagination and in public health funding, with contemporary treatments running into thousands of dollars per patient annually.   But was there a cure for AIDS all this time - an affordable and safe treatment that was ruthlessly suppressed and attacked by the US public health bureaucracy and its agents? Could this have saved millions of lives and billions of dollars spent on AZT, ddI and failed HIV vaccine trials? What could possibly justify the decision to disappear a safe and effective approach down the memory hole?   The inventor of the cure, Gary Null, already had several decades of experience creating healing protocols for physicians to help patients not responding well to conventional treatments by the time AIDS was officially defined in 1981. Null, a registered dietitian and board-certified nutritionist with a PhD in human nutrition and public health science, was a senior research fellow and Director of Anti-Aging Medicine at the Institute of Applied Biology for 36 years and has published over 950 papers, conducting groundbreaking experiments in reversing biological aging as confirmed with DNA methylation testing. Additionally, Null is a multi-award-winning documentary filmmaker, bestselling author, and investigative journalist whose work exposing crimes against humanity over the last 50 years has highlighted abuses by Big Pharma, the military-industrial complex, the financial industry, and the permanent government stay-behind networks that have come to be known as the Deep State.   Null was contacted in 1974 by Dr. Stephen Caiazza, a physician working with a subculture of gay men in New York living the so-called “fast track” lifestyle, an extreme manifestation of the gay liberation movement that began with the Stonewall riots. Defined by rampant sexual promiscuity and copious use of illegal and prescription drugs, including heavy antibiotic use for a cornucopia of sexually-transmitted diseases, the fast-track never included more than about two percent of gay men, though these dominated many of the bathhouses and clubs that defined gay nightlife in the era. These patients had become seriously ill as a result of their indulgence, generally arriving at the clinic with multiple STDs including cytomegalovirus and several types of herpes and hepatitis, along with candida overgrowth, nutritional deficiencies, gut issues, and recurring pneumonia. Every week for the next 10 years, Null would counsel two or three of these men - a total of 800 patients - on how to detoxify their bodies and de-stress their lives, tracking their progress with Caiazza and the other providers at weekly feedback meetings that he credits with allowing the team to quickly evaluate which treatments were most effective. He observed that it only took about two years on the “fast track” for a healthy young person to begin seeing muscle loss and the recurrent, lingering opportunistic infections that would later come to be associated with AIDS - while those willing to commit to a healthier lifestyle could regain their health in about a year.    It was with this background that Null established the Tri-State Healing Center in Manhattan in 1980, staffing the facility with what would eventually run to 22 certified health professionals to offer safe, natural, and effective low- and no-cost treatments to thousands of patients with HIV and AIDS-defining conditions. Null and his staff used variations of the protocols he had perfected with Caiazza's patients, a multifactorial patient-tailored approach that included high-dose vitamin C drips, intravenous ozone therapy, juicing and nutritional improvements and supplementation, aspects of homeopathy and naturopathy with some Traditional Chinese Medicine and Ayurvedic practices. Additional services offered on-site included acupuncture and holistic dentistry, while peer support groups were also held at the facility so that patients could find community and a positive environment, healing their minds and spirits while they healed their bodies.   “Instead of trying to kill the virus with antiretroviral pharmaceuticals designed to stop viral replication before it kills patients, we focused on what benefits could be gained by building up the patients' natural immunity and restoring biochemical integrity so the body could fight for itself,” Null wrote in a 2014 article describing the philosophy behind the Center's approach, which was wholly at odds with the pharmaceutical model.1   Patients were comprehensively tested every week, with any “recovery” defined solely by the labs, which documented AIDS patient after patient - 1,200 of them - returning to good health and reversing their debilitating conditions. Null claims to have never lost an AIDS patient in the Center's care, even as the death toll for the disease - and its pharmaceutical standard of care AZT - reached an all-time high in the early 1990s. Eight patients who had opted for a more intensive course of treatment - visiting the Center six days a week rather than one - actually sero-deconverted, with repeated subsequent testing showing no trace of HIV in their bodies.   As an experienced clinical researcher himself, Null recognized that any claims made by the Center would be massively scrutinized, challenging as they did the prevailing scientific consensus that AIDS was an incurable, terminal illness. He freely gave his protocols to any medical practitioner who asked, understanding that his own work could be considered scientifically valid only if others could replicate it under the same conditions. After weeks of daily observational visits to the Center, Dr. Robert Cathcart took the protocols back to San Francisco, where he excitedly reported that patients were no longer dying in his care.    Null's own colleague at the Institute of Applied Biology, senior research fellow Elana Avram, set up IV drip rooms at the Institute and used his intensive protocols to sero-deconvert 10 patients over a two-year period. While the experiment had been conducted in secret, as the Institute had been funded by Big Pharma since its inception half a century earlier, Avram had hoped she would be able to publish a journal article to further publicize Null's protocols and potentially help AIDS patients, who were still dying at incredibly high rates thanks to Burroughs Wellcome's noxious but profitable AZT. But as she would later explain in a 2019 letter to Null, their groundbreaking research never made it into print - despite meticulous documentation of their successes - because the Institute's director and board feared their pharmaceutical benefactors would withdraw the funding on which they depended, given that Null's protocols did not involve any patentable or otherwise profitable drugs. When Avram approached them about publication, the board vetoed the idea, arguing that it would “draw negative attention because [the work] was contrary to standard drug treatments.” With no real point in continuing experiments along those lines without institutional support and no hope of obtaining funding from elsewhere, the department she had created specifically for these experiments shut down after a two-year followup with her test subjects - all of whom remained alive and healthy - was completed.2   While the Center was receiving regular visits by this time from medical professionals and, increasingly, black celebrities like Stokely Carmichael and Isaac Hayes, who would occasionally perform for the patients, the news was spreading by word of mouth alone - not a single media outlet had dared to document the clinic that was curing AIDS patients for free. Instead, they gave airtime to Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases, who had for years been spreading baseless, hysteria-fueling claims about HIV and AIDS to any news outlet that would put him on. His claim that children could contract the virus from “ordinary household conduct” with an infected relative proved so outrageous he had to walk it back,3 and he never really stopped insisting the deadly plague associated with gays and drug users was about to explode like a nuclear bomb among the law-abiding heterosexual population. Fauci by this time controlled all government science funding through NIAID, and his zero-tolerance approach to dissent on the HIV/AIDS front had already seen prominent scientists like virologist Peter Duesberg stripped of the resources they needed for their work because they had dared to question his commandment: There is no cause of AIDS but HIV, and AZT is its treatment. Even the AIDS activist groups, which by then had been coopted by Big Pharma and essentially reduced to astroturfing for the toxic failed chemotherapy drug AZT backed by the institutional might of Fauci's NIAID,4 didn't seem to want to hear that there was a cure. Unconcerned with the irrationality of denouncing the man touting his free AIDS cure as an  “AIDS denier,” they warned journalists that platforming Null or anyone else rejecting the mainstream medical line would be met with organized demands for their firing.    Determined to breach the institutional iron curtain and get his message to the masses, Null and his team staged a press conference in New York, inviting scientists and doctors from around the world to share their research on alternative approaches to HIV and AIDS in 1993. To emphasize the sound scientific basis of the Center's protocols and encourage guests to adopt them into their own practices, Null printed out thousands of abstracts in support of each nutrient and treatment being used. However, despite over 7,000 invitations sent three times to major media, government figures, scientists, and activists, almost none of the intended audience members showed up. Over 100 AIDS patients and their doctors, whose charts exhaustively documented their improvements using natural and nontoxic modalities over the preceding 12 months, gave filmed testimonials, declaring that the feared disease was no longer a death sentence, but the conference had effectively been silenced. Bill Tatum, publisher of the Amsterdam News, suggested Null and his patients would find a more welcoming audience in his home neighborhood of Harlem - specifically, its iconic Apollo Theatre. For three nights, the theater was packed to capacity. Hit especially hard by the epidemic and distrustful of a medical system that had only recently stopped being openly racist (the Tuskegee syphilis experiment only ended in 1972), black Americans, at least, did not seem to care what Anthony Fauci would do if he found out they were investigating alternatives to AZT and death.    PBS journalist Tony Brown, having obtained a copy of the video of patient testimonials from the failed press conference, was among a handful of black journalists who began visiting the Center to investigate the legitimacy of Null's claims. Satisfied they had something significant to offer his audience, Brown invited eight patients - along with Null himself - onto his program over the course of several episodes to discuss the work. It was the first time these protocols had received any attention in the media, despite Null having released nearly two dozen articles and multiple documentaries on the subject by that time. A typical patient on one program, Al, a recovered IV drug user who was diagnosed with AIDS at age 32, described how he “panicked,” saw a doctor and started taking AZT despite his misgivings - only to be forced to discontinue the drug after just a few weeks due to his condition deteriorating rapidly. Researching alternatives brought him to Null, and after six months of “detoxing [his] lifestyle,” he observed his initial symptoms - swollen lymph nodes and weight loss - begin to reverse, culminating with sero-deconversion. On Bill McCreary's Channel 5 program, a married couple diagnosed with HIV described how they watched their T-cell counts increase as they cut out sugar, caffeine, smoking, and drinking and began eating a healthy diet. They also saw the virus leave their bodies.   For HIV-positive viewers surrounded by fear and negativity, watching healthy-looking, cheerful “AIDS patients” detail their recovery while Null backed up their claims with charts must have been balm for the soul. But the TV programs were also a form of outreach to the medical community, with patients' charts always on hand to convince skeptics the cure was scientifically valid. Null brought patients' charts to every program, urging them to keep an open mind: “Other physicians and public health officials should know that there's good science in the alternative perspective. It may not be a therapy that they're familiar with, because they're just not trained in it, but if the results are positive, and you can document them…” He challenged doubters to send in charts from their own sero-deconverted patients on AZT, and volunteered to debate proponents of the orthodox treatment paradigm - though the NIH and WHO both refused to participate in such a debate on Tony Brown's Journal, following Fauci's directive prohibiting engagement with forbidden ideas.    Aside from those few TV programs and Null's own films, suppression of Null's AIDS cure beyond word of mouth was total. The 2021 documentary The Cost of Denial, produced by the Society for Independent Journalists, tells the story of the Tri-State Healing Center and the medical paradigm that sought to destroy it, lamenting the loss of the lives that might have been saved in a more enlightened society. Nurse practitioner Luanne Pennesi, who treated many of the AIDS patients at the Center, speculated in the film that the refusal by the scientific establishment and AIDS activists to accept their successes was financially motivated. “It was as if they didn't want this information to get out. Understand that our healthcare system as we know it is a corporation, it's a corporate model, and it's about generating revenue. My concern was that maybe they couldn't generate enough revenue from these natural approaches.”5   Funding was certainly the main disciplinary tool Fauci's NIAID used to keep the scientific community in line. Despite the massive community interest in the work being done at the Center, no foundation or institution would defy Fauci and risk getting itself blacklisted, leaving Null to continue funding the operation out of his pocket with the profits from book sales. After 15 years, he left the Center in 1995, convinced the mainstream model had so thoroughly been institutionalized that there was no chance of overthrowing it. He has continued to counsel patients and advocate for a reappraisal of the HIV=AIDS hypothesis and its pharmaceutical treatments, highlighting the deeply flawed science underpinning the model of the disease espoused by the scientific establishment in 39 articles, six documentaries and a 700-page textbook on AIDS, but the Center's achievements have been effectively memory-holed by Fauci's multi-billion-dollar propaganda apparatus.     FRUIT OF THE POISONOUS TREE   To understand just how much of a threat Null's work was to the HIV/AIDS establishment, it is instructive to revisit the 1984 paper, published by Dr. Robert Gallo of the National Cancer Institute, that established HIV as the sole cause of AIDS. The CDC's official recognition of AIDS in 1981 had done little to quell the mounting public panic over the mysterious illness afflicting gay men in the US, as the agency had effectively admitted it had no idea what was causing them to sicken and die. As years passed with no progress determining the causative agent of the plague, activist groups like Gay Men's Health Crisis disrupted public events and threatened further mass civil disobedience as they excoriated the NIH for its sluggish allocation of government science funding to uncovering the cause of the “gay cancer.”6 When Gallo published his paper declaring that the retrovirus we now know as HIV was the sole “probable” cause of AIDS, its simple, single-factor hypothesis was the answer to the scientific establishment's prayers. This was particularly true for Fauci, as the NIAID chief was able to claim the hot new disease as his agency's own domain in what has been described as a “dramatic confrontation” with his rival Sam Broder at the National Cancer Institute. After all, Fauci pointed out, Gallo's findings - presented by Health and Human Services Secretary Margaret Heckler as if they were gospel truth before any other scientists had had a chance to inspect them, never mind conduct a full peer review - clearly classified AIDS as an infectious disease, and not a cancer like the Kaposi's sarcoma which was at the time its most visible manifestation. Money and media attention began pouring in, even as funding for the investigation of other potential causes of AIDS dried up. Having already patented a diagnostic test for “his” retrovirus before introducing it to the world, Gallo was poised for a financial windfall, while Fauci was busily leveraging the discovery into full bureaucratic empire of the US scientific apparatus.   While it would serve as the sole basis for all US government-backed AIDS research to follow - quickly turning Gallo into the most-cited scientist in the world during the 1980s,7 Gallo's “discovery” of HIV was deeply problematic. The sample that yielded the momentous discovery actually belonged to Prof. Luc Montagnier of the French Institut Pasteur, a fact Gallo finally admitted in 1991, four years after a lawsuit from the French government challenged his patent on the HIV antibody test, forcing the US government to negotiate a hasty profit-sharing agreement between Gallo's and Montagnier's labs. That lawsuit triggered a cascade of official investigations into scientific misconduct by Gallo, and evidence submitted during one of these probes, unearthed in 2008 by journalist Janine Roberts, revealed a much deeper problem with the seminal “discovery.” While Gallo's co-author, Mikulas Popovic, had concluded after numerous experiments with the French samples that the virus they contained was not the cause of AIDS, Gallo had drastically altered the paper's conclusion, scribbling his notes in the margins, and submitted it for publication to the journal Science without informing his co-author.   After Roberts shared her discovery with contacts in the scientific community, 37 scientific experts wrote to the journal demanding that Gallo's career-defining HIV paper be retracted from Science for lacking scientific integrity.8 Their call, backed by an endorsement from the 2,600-member scientific organization Rethinking AIDS, was ignored by the publication and by the rest of mainstream science despite - or perhaps because of - its profound implications.   That 2008 letter, addressed to Science editor-in-chief Bruce Alberts and copied to American Association for the Advancement of Science CEO Alan Leshner, is worth reproducing here in its entirety, as it utterly dismantles Gallo's hypothesis - and with them the entire HIV is the sole cause of AIDS dogma upon which the contemporary medical model of the disease rests:   On May 4, 1984 your journal published four papers by a group led by Dr. Robert Gallo. We are writing to express our serious concerns with regard to the integrity and veracity of the lead paper among these four of which Dr. Mikulas Popovic is the lead author.[1] The other three are also of concern because they rely upon the conclusions of the lead paper .[2][3][4]  In the early 1990s, several highly critical reports on the research underlying these papers were produced as a result of governmental inquiries working under the supervision of scientists nominated by the National Academy of Sciences and the Institute of Medicine. The Office of Research Integrity of the US Department of Health and Human Services concluded that the lead paper was “fraught with false and erroneous statements,” and that the “ORI believes that the careless and unacceptable keeping of research records...reflects irresponsible laboratory management that has permanently impaired the ability to retrace the important steps taken.”[5] Further, a Congressional Subcommittee on Oversight and Investigations led by US Representative John D. Dingell of Michigan produced a staff report on the papers which contains scathing criticisms of their integrity.[6]  Despite the publically available record of challenges to their veracity, these papers have remained uncorrected and continue to be part of the scientific record.  What prompts our communication today is the recent revelation of an astonishing number of previously unreported deletions and unjustified alterations made by Gallo to the lead paper. There are several documents originating from Gallo's laboratory that, while available for some time, have only recently been fully analyzed. These include a draft of the lead paper typewritten by Popovic which contains handwritten changes made to it by Gallo.[7] This draft was the key evidence used in the above described inquiries to establish that Gallo had concealed his laboratory's use of a cell culture sample (known as LAV) which it received from the Institut Pasteur.  These earlier inquiries verified that the typed manuscript draft was produced by Popovic who had carried out the recorded experiment while his laboratory chief, Gallo, was in Europe and that, upon his return, Gallo changed the document by hand a few days before it was submitted to Science on March 30, 1984. According to the ORI investigation, “Dr. Gallo systematically rewrote the manuscript for what would become a renowned LTCB [Gallo's laboratory at the National Cancer Institute] paper.”[5]  This document provided the important evidence that established the basis for awarding Dr. Luc Montagnier and Dr. Francoise Barré-Sinoussi the 2008 Nobel Prize in Medicine for the discovery of the AIDS virus by proving it was their samples of LAV that Popovic used in his key experiment. The draft reveals that Popovic had forthrightly admitted using the French samples of LAV renamed as Gallo's virus, HTLV-III, and that Gallo had deleted this admission, concealing their use of LAV.  However, it has not been previously reported that on page three of this same document Gallo had also deleted Popovic's unambiguous statement that, "Despite intensive research efforts, the causative agent of AIDS has not yet been identified,” replacing it in the published paper with a statement that said practically the opposite, namely, “That a retrovirus of the HTLV family might be an etiologic agent of AIDS was suggested by the findings.”  It is clear that the rest of Popovic's typed paper is entirely consistent with his statement that the cause of AIDS had not been found, despite his use of the French LAV. Popovic's final conclusion was that the culture he produced “provides the possibility” for detailed studies. He claimed to have achieved nothing more. At no point in his paper did Popovic attempt to prove that any virus caused AIDS, and it is evident that Gallo concealed these key elements in Popovic's experimental findings.  It is astonishing now to discover these unreported changes to such a seminal document. We can only assume that Gallo's alterations of Popovic's conclusions were not highlighted by earlier inquiries because the focus at the time was on establishing that the sample used by Gallo's lab came from Montagnier and was not independently collected by Gallo. In fact, the only attention paid to the deletions made by Gallo pertains to his effort to hide the identity of the sample. The questions of whether Gallo and Popovic's research proved that LAV or any other virus was the cause of AIDS were clearly not considered.  Related to these questions are other long overlooked documents that merit your attention. One of these is a letter from Dr. Matthew A. Gonda, then Head of the Electron Microscopy Laboratory at the National Cancer Institute, which is addressed to Popovic, copied to Gallo and dated just four days prior to Gallo's submission to Science.[8] In this letter, Gonda remarks on samples he had been sent for imaging because “Dr Gallo wanted these micrographs for publication because they contain HTLV.” He states, “I do not believe any of the particles photographed are of HTLV-I, II or III.” According to Gonda, one sample contained cellular debris, while another had no particles near the size of a retrovirus. Despite Gonda's clearly worded statement, Science published on May 4, 1984 papers attributed to Gallo et al with micrographs attributed to Gonda and described unequivocally as HTLV-III.  In another letter by Gallo, dated one day before he submitted his papers to Science, Gallo states, “It's extremely rare to find fresh cells [from AIDS patients] expressing the virus... cell culture seems to be necessary to induce virus,” a statement which raises the possibility he was working with a laboratory artifact. [9]  Included here are copies of these documents and links to the same. The very serious flaws they reveal in the preparation of the lead paper published in your journal in 1984 prompts our request that this paper be withdrawn. It appears that key experimental findings have been concealed. We further request that the three associated papers published on the same date also be withdrawn as they depend on the accuracy of this paper.  For the scientific record to be reliable, it is vital that papers shown to be flawed, or falsified be retracted. Because a very public record now exists showing that the Gallo papers drew unjustified conclusions, their withdrawal from Science is all the more important to maintain integrity. Future researchers must also understand they cannot rely on the 1984 Gallo papers for statements about HIV and AIDS, and all authors of papers that previously relied on this set of four papers should have the opportunity to consider whether their own conclusions are weakened by these revelations.      Gallo's handwritten revision, submitted without his colleague's knowledge despite multiple experiments that failed to support the new conclusion, was the sole foundation for the HIV=AIDS hypothesis. Had Science published the manuscript the way Popovic had typed it, there would be no AIDS “pandemic” - merely small clusters of people with AIDS. Without a viral hypothesis backing the development of expensive and deadly pharmaceuticals, would Fauci have allowed these patients to learn about the cure that existed all along?   Faced with a potential rebellion, Fauci marshaled the full resources under his control to squelch the publication of the investigations into Gallo and restrict any discussion of competing hypotheses in the scientific and mainstream press, which had been running virus-scare stories full-time since 1984. The effect was total, according to biochemist Dr. Kary Mullis, inventor of the polymerase chain reaction (PCR) procedure. In a 2009 interview, Mullis recalled his own shock when he attempted to unearth the experimental basis for the HIV=AIDS hypothesis. Despite his extensive inquiry into the literature, “there wasn't a scientific reference…[that] said ‘here's how come we know that HIV is the probable cause of AIDS.' There was nothing out there like that.”9 This yawning void at the core of HIV/AIDS “science" turned him into a strident critic of AIDS dogma - and those views made him persona non grata where the scientific press was concerned, suddenly unable to publish a single paper despite having won the Nobel Prize for his invention of the PCR test just weeks before.  10   DISSENT BECOMES “DENIAL”   While many of those who dissent from the orthodox HIV=AIDS view believe HIV plays a role in the development of AIDS, they point to lifestyle and other co-factors as being equally if not more important. Individuals who test positive for HIV can live for decades in perfect health - so long as they don't take AZT or the other toxic antivirals fast-tracked by Fauci's NIAID - but those who developed full-blown AIDS generally engaged in highly risky behaviors like extreme promiscuity and prodigious drug abuse, contracting STDs they took large quantities of antibiotics to treat, further running down their immune systems. While AIDS was largely portrayed as a “gay disease,” it was only the “fast track” gays, hooking up with dozens of partners nightly in sex marathons fueled by “poppers” (nitrate inhalants notorious for their own devastating effects on the immune system), who became sick. Kaposi's sarcoma, one of the original AIDS-defining conditions, was widespread among poppers-using gay men, but never appeared among IV drug users or hemophiliacs, the other two main risk groups during the early years of the epidemic. Even Robert Gallo himself, at a 1994 conference on poppers held by the National Institute on Drug Abuse, would admit that the previously-rare form of skin cancer surging among gay men was not primarily caused by HIV - and that it was immune stimulation, rather than suppression, that was likely responsible.11 Similarly, IV drug users are often riddled with opportunistic infections as their habit depresses the immune system and their focus on maintaining their addiction means that healthier habits - like good nutrition and even basic hygiene - fall by the wayside.    Supporting the call for revising the HIV=AIDS hypothesis to include co-factors is the fact that the mass heterosexual outbreaks long predicted by Fauci and his ilk in seemingly every country on Earth have failed to materialize, except - supposedly - in Africa, where the diagnostic standard for AIDS differs dramatically from those of the West. Given the prohibitively high cost of HIV testing for poor African nations, the WHO in 1985 crafted a diagnostic loophole that became known as the “Bangui definition,” allowing medical professionals to diagnose AIDS in the absence of a test using just clinical symptoms: high fever, persistent cough, at least 30 days of diarrhea, and the loss of 10% of one's body weight within two months. Often suffering from malnutrition and without access to clean drinking water, many of the inhabitants of sub-Saharan Africa fit the bill, especially when the WHO added tuberculosis to the list of AIDS-defining illnesses in 1993 - a move which may be responsible for as many as one half of African “AIDS” cases, according to journalist Christine Johnson. The WHO's former Chief of Global HIV Surveillance, James Chin, acknowledged their manipulation of statistics, but stressed that it was the entire AIDS industry - not just his organization - perpetrating the fraud. “There's the saying that, if you knew what sausages are made of, most people would hesitate to sort of eat them, because they wouldn't like what's in it. And if you knew how HIV/AIDS numbers are cooked, or made up, you would use them with extreme caution,” Chin told an interviewer in 2009.12   With infected numbers stubbornly remaining constant in the US despite Fauci's fearmongering projections of the looming heterosexually-transmitted plague, the CDC in 1993 broadened its definition of AIDS to include asymptomatic (that is, healthy) HIV-positive people with low T-cell counts - an absurd criteria given that an individual's T-cell count can fluctuate by hundreds within a single day. As a result, the number of “AIDS cases” in the US immediately doubled. Supervised by Fauci, the NIAID had been quietly piling on diseases into the “AIDS-related” category for years, bloating the list from just two conditions - pneumocystis carinii pneumonia and Kaposi's sarcoma - to 30 so fast it raised eyebrows among some of science's leading lights. Deeming the entire process “bizarre” and unprecedented, Kary Mullis wondered aloud why no one had called the AIDS establishment out: “There's something wrong here. And it's got to be financial.”13   Indeed, an early CDC public relations campaign was exposed by the Wall Street Journal in 1987 as having deliberately mischaracterized AIDS as a threat to the entire population so as to garner increased public and private funding for what was very much a niche issue, with the risk to average heterosexuals from a single act of sex “smaller than the risk of ever getting hit by lightning.” Ironically, the ads, which sought to humanize AIDS patients in an era when few Americans knew anyone with the disease and more than half the adult population thought infected people should be forced to carry cards warning of their status, could be seen as a reaction to the fear tactics deployed by Fauci early on.14   It's hard to tell where fraud ends and incompetence begins with Gallo's HIV antibody test. Much like Covid-19 would become a “pandemic of testing,” with murder victims and motorcycle crashes lumped into “Covid deaths” thanks to over-sensitized PCR tests that yielded as many as 90% false positives,15 HIV testing is fraught with false positives - and unlike with Covid-19, most people who hear they are HIV-positive still believe they are receiving a death sentence. Due to the difficulty of isolating HIV itself from human samples, the most common diagnostic tests, ELISA and the Western Blot, are designed to detect not the virus but antibodies to it, upending the traditional medical understanding that the presence of antibodies indicates only exposure - and often that the body has actually vanquished the pathogen. Patients are known to test positive for HIV antibodies in the absence of the virus due to at least 70 other conditions, including hepatitis, lupus, rheumatoid arthritis, syphilis, recent vaccination or even pregnancy. (https://www.chcfl.org/diseases-that-can-cause-a-false-positive-hiv-test/) Positive results are often followed up with a PCR “viral load” test, even though the inventor of the PCR technique Kary Mullis famously condemned its misuse as a tool for diagnosing infection. Packaging inserts for all three tests warn the user that they cannot be reliably used to diagnose HIV.16 The ELISA HIV antibody test explicitly states: “At present there is no recognized standard for establishing the presence and absence of HIV antibody in human blood.”17   That the public remains largely unaware of these and other massive holes in the supposedly airtight HIV=AIDS=DEATH paradigm is a testament to Fauci's multi-layered control of the press. Like the writers of the Great Barrington Declaration and other Covid-19 dissidents, scientists who question HIV/AIDS dogma have been brutally punished for their heresy, no matter how prestigious their prior standing in the field and no matter how much evidence they have for their own claims. In 1987, the year the FDA's approval of AZT made AIDS the most profitable epidemic yet (a dubious designation Covid-19 has since surpassed), Fauci made it clearer than ever that scientific inquiry and debate - the basis of the scientific method - would no longer be welcome in the American public health sector, eliminating retrovirologist Peter Duesberg, then one of the most prominent opponents of the HIV=AIDS hypothesis, from the scientific conversation with a professional disemboweling that would make a cartel hitman blush. Duesberg had just eviscerated Gallo's 1984 HIV paper with an article of his own in the journal Cancer Research, pointing out that retroviruses had never before been found to cause a single disease in humans - let alone 30 AIDS-defining diseases. Rather than allow Gallo or any of the other scientists in his camp to respond to the challenge, Fauci waged a scorched-earth campaign against Duesberg, who had until then been one of the most highly regarded researchers in his field. Every research grant he requested was denied; every media appearance was canceled or preempted. The University of California at Berkeley, unable to fully fire him due to tenure, took away his lab, his graduate students, and the rest of his funding. The few colleagues who dared speak up for him in public were also attacked, while enemies and opportunists were encouraged to slander Duesberg at the conferences he was barred from attending and in the journals that would no longer publish his replies. When Duesberg was summoned to the White House later that year by then-President Ronald Reagan to debate Fauci on the origins of AIDS, Fauci convinced the president to cancel, allegedly pulling rank on the Commander-in-Chief with an accusation that the “White House was interfering in scientific matters that belonged to the NIH and the Office of Science and Technology Assessment.” After seven years of this treatment, Duesberg was contacted by NIH official Stephen O'Brien and offered an escape from professional purgatory. He could have “everything back,” he was told, and shown a manuscript of a scientific paper - apparently commissioned by the editor of the journal Nature - “HIV Causes AIDS: Koch's Postulates Fulfilled” with his own name listed alongside O'Brien's as an author.18 His refusal to take the bribe effectively guaranteed the epithet “AIDS denier” will appear on his tombstone. The character assassination of Duesberg became a template that would be deployed to great effectiveness wherever Fauci encountered dissent - never debate, only demonize, deplatform and destroy.    Even Luc Montagnier, the real discoverer of HIV, soon found himself on the wrong side of the Fauci machine. With his 1990 declaration that “the HIV virus [by itself] is harmless and passive, a benign virus,” Montagnier began distancing himself from Gallo's fraud, effectively placing a target on his own back. In a 1995 interview, he elaborated: “four factors that have come together to account for the sudden epidemic [of AIDS]: HIV presence, immune hyper-activation, increased sexually transmitted disease incidence, sexual behavior changes and other behavioral changes” such as drug use, poor nutrition and stress - all of which he said had to occur “essentially simultaneously” for HIV to be transmitted, creating the modern epidemic. Like the professionals at the Tri-State Healing Center, Montagnier advocated for the use of antioxidants like vitamin C and N-acetyl cysteine, naming oxidative stress as a critical factor in the progression from HIV to AIDS.19 When Montagnier died in 2022, Fauci's media mouthpieces sneered that the scientist (who was awarded the Nobel Prize in 2008 for his discovery of HIV, despite his flagging faith in that discovery's significance) “started espousing views devoid of a scientific basis” in the late 2000s, leading him to be “shunned by the scientific community.”20 In a particularly egregious jab, the Washington Post's obit sings the praises of Robert Gallo, implying it was the American scientist who really should have won the Nobel for HIV, while dismissing as “

Amy is joined by lawyer and author, Iris Mwanza, to discuss her novel - The Lion's Den - plus the status of patriarchy in Zambia, worldwide, and the critical role that books play in shaping public attitudes.Donate to Breaking Down PatriarchyIris Mwanza is a Zambian-American author and gender equality advocate. Born and raised in Zambia, early exposure to inequality has been a driving force in her life - from becoming a lawyer, writing a Ph.D. dissertation on women and children's rights, a career fighting for gender equality, and now a thriller with gender equality as its heart.Iris has spent an inordinate amount of time studying and has law degrees from Cornell University and the University of Zambia, and an M.A. and Ph.D. in International Relations from Johns Hopkins School of Advanced International Studies. Her day job is Deputy Director of the Women in Leadership team in the Gender Equality Division of the Bill & Melinda Gates Foundation, and her night job is to write. Her debut novel The Lions' Den took nine years of nights and weekends to finish.

Farming is the number one source of employment in Africa, yet its agricultural productivity is the lowest of any region in the world. The opportunity is immense—60% of the world's uncultivated arable land is on the continent—but rural communities are suffering from a lack of economic opportunity.So young Africans are building innovative solutions to tackle the problems that are impacting their families and communities.Wissal Ben Moussa is the Co-founder & R&D Officer of Sand To Green, a Moroccan startup pairing regenerative agroforestry techniques with data and technology to turn the desert green. Samuel Rigu is the Co-founder & CEO of Safi Organics, a Kenyan company employing a decentralized process to locally manufacture organic fertilizers. Francis Nderitu is the Founder of Keep IT Cool, a recent Earthshot Prize winner, building cold chain storage to reduce post-harvest losses in Kenya. 00:00 - Africa has the lowest farming productivity in the world01:08 - Sand to Green is reversing desertification in Morocco04:30 - Safi Organics is manufacturing organic fertilizers in Kenya07:23 - Keep IT Cool is reducing post-harvest loss in Kenya10:15 - Solving problems for their local communitiesCheck out more episodes of The Greenprint here.This episode was produced as part of our series on climate action in Africa, The Greenprint, in partnership with Catalyst Fund, Delta40, Africa Climate Ventures, and AgBase - an initiative powered by Briter and Mercy Corps AgriFin.AgBase is a business intelligence platform offering real-time data, market insights, and a centralised hub for information on agtech and foodtech across emerging markets. This initiative, backed by the Bill and Melinda Gates Foundation and The Foreign, Commonwealth & Development Office (FCDO), and hosted by Briter Bridges in partnership with MercyCorps AgriFin, is dedicated to bolstering the knowledge framework essential for catalysing investments in digital and technology-driven solutions, with an underlying mission is to transform the lives of smallholder farmers and boost socio-economic growth.Delta40 is a venture studio and venture capital fund supporting diverse founders leading ventures in energy, agriculture, and fintech, with a special focus on supporting African and female entrepreneurs. Beyond capital, they provide hands-on support from experienced operators & investors to drive growth from idea to pan-African scale. Africa Climate Ventures is a pioneering venture builder working to build a portfolio of climate businesses on the continent. ACV invests to bring proven global climate technology to Africa, accelerate and de-risk the continental expansion of technologies and business models that have gained traction in one or a few African market(s), and add carbon revenue streams to existing African businesses with the potential to scale climate-positive solutions.‍Catalyst Fund is a venture capital fund and venture builder, investing for a climate resilient future in Africa. They combine capital and a hands-on venture-building approach at the pre-seed stage, to partner with visionary founders who are developing climate adaptation solutions that enhance the resilience of communities and the planet.This episode is made possible through a partnership with Prosper Africa's Catalytic Investment Facility. Aimed at boosting investment and innovative climate adaptation and resilience ventures across Africa, The Catalyst Fund is one of the grantees under Prosper Africa's Catalytic Investment Facility. Prosper Africa is a Presidential-level national security initiative aimed at strengthening the strategic and economic partnership between the U.S. and Africa by catalyzing transformative two-way trade and investment flows.Our Links -

Send us a textIn this episode, I'm joined by sales specialist Nikki Rausch, a master in recognizing and responding to buying signals. With 25+ years of experience selling to prestigious organizations like The Bill & Melinda Gates Foundation and NASA, Nikki shattered sales records and received “top producer” awards along the way.Today, entrepreneurs and small business owners hire Nikki to show them how to sell successfully and authentically.Nikki has written 3 books, all available on Amazon. And she has a podcast called Sales Maven which you can find on your favorite podcast platform.instagram: @your_sales_mavenBe sure to follow along on Instagram @thebusinessofbeautifulspaces + @thorntondesign to stay up to date on what we're talking about next week. If you love our podcast, please, please, please leave us a review. If you have any questions or topic ideas OR you wish to be a guest email us thebusinessofbeautifulspaces@gmail.com or find us on instagram @thebusinessofbeautifulspacesLaura Thornton is the principle designer of Thornton Design Inc, located in Kleinburg, ON. Since founding the company in 1999, Laura has been committed to creating a new kind of interior design experience for her clients. Thornton Design is an experienced team of creative talents, focused on curating beautiful residential and commercial spaces in the Toronto, Ontario area and beyond. Now sharing all the years of experience with other interior designers to create a world of collaboration and less competition. The Business of Beautiful Spaces I @thebusinessofbeautifulspacesThornton Design I @thorntondesign

In this week's episode, both of our storytellers experience a shift in how they see themselves. Part 1: Fangfang Ruose fears that her prosthetic legs will exclude her from becoming a fashion model. Part 2: When engineering student Devan Sandiford runs into an old friend from his former college, he desperately wants her to think he's cool. Fangfang Ruose is originally from a small village in China and grew up in a Chinese Catholic orphanage, where she received her first prosthetics at the age of three. Later, she was adopted by an American father and a Spanish mother, and moved to Miami as a teenager. She graduated from FIU with a Bachelor's in Finance and is now pursuing a Master's in International Real Estate and Finance, focusing on development. Alongside her studies, she models, proudly showcasing her prosthetics and embracing her unique journey to advocate for body positivity and self-acceptance. Devan Sandiford is a published writer, award-winning storyteller, and community activist. His stories have been featured in The Washington Post, NPR, The Moth Podcast, Story Collider, Simple Families Podcast, Speak Up Storytelling, and elsewhere. He is an alumni of and former writer-in-residence at the Voices of Our Nations Arts Foundation (VONA), a finalist for The Kenyon Review Developmental Editing Fellowship for Emerging Writers, and a recipient of the Corporeal Writing Scholarship for Writing Trauma Toward Healing and Joy with Terese Maria Mailhot. He has a poem in the anthology Excitement and Talisman (2023) and an essay in the anthology Bodies of Stories (2022). Devan has contributed his opinions on race, identity, grief, parenting, and storytelling for articles in The New York Times, The Washington Post, and Slate Magazine. He has received acclaim from multiple New York Times bestselling authors, including Roxane Gay, who called him "an excellent writer who will be endlessly interesting to his readers." Devan lives in Brooklyn, New York with his wife and their two sons and works as a story developer at The Bill & Melinda Gates Foundation. He loves brunch, biking in a morning chill, bookstore crawls, and being roasted on his birthday. Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the Getting Smart Podcast, in today's episode, we dive into the innovative initiatives of District 214, a leader in creating personalized, real-world learning experiences for students. Supported by the Bill and Melinda Gates Foundation, District 214 is part of the Illinois Accelerate Ed cohort, focusing on bridging K-12 education with postsecondary opportunities and careers. Join us as we speak with Dr. Lazaro Lopez, Associate Superintendent, and inspiring students Ayana and Georgie, who share their unique paths in healthcare and engineering. Discover how these learners are navigating their futures with confidence and purpose in an ever-evolving world. Outline (00:00) Introduction to the Getting Smart Podcast (02:11) Georgie's Journey in Engineering (05:05) Ayanna's Path to Medicine (09:36) The Role of Educators and Industry Connections (16:09) Success Metrics and Future Directions Links: Watch the full video Read the full blog here Illinois Accelerate ED Dr. Lazaro Lopez LinkedIn D214 Pathways Handbook

When Rajiv Shah was in his late 20s and didn't know what to do with his life, he got a job at a fledgling nonprofit, the Bill and Melinda Gates Foundation. Before he knew it, he was a driving force behind a global vaccination program that immunized 900 million children and saved 16 million lives. At 36, he became the administrator of the United States Agency for International Development (USAID), managing a $20 billion budget, overseeing a staff of 10,000, and leading the U.S. response to global humanitarian crises. Today, as president of the Rockefeller Foundation, he's finding innovative solutions to mitigate climate change and end energy poverty. What connects these experiences? At every step, Raj maintained a big bet mentality. What is a big bet? “A concerted effort to fundamentally solve a single, pressing problem in your community or our world. Big bets require setting profound, seemingly unachievable goals and believing they are achievable.” In this episode, he shares his methodology for creating large-scale change and making the world a better place. (This episode was first broadcast in 2024.)

Meghan Corroon is the Co-founder and CEO of Clerdata, a marketing intelligence platform that drives sales. As a data scientist, she has completed data science research for several national governments in Africa. Before co-founding Clerdata, Meghan was the Technical Director for the University of North Carolina at Chapel Hill's Bill and Melinda Gates Foundation portfolio evaluation. In this episode… Retail media has evolved from a “growth at all costs” strategy to a demand for measurable ROI, forcing brands to rethink their ad investments. With nearly 700 retail media networks, companies struggle to allocate their budgets. As executives face increasing pressure to justify spending, incrementality measurement has emerged as a crucial tool for identifying retail media's impact on sales and profitability. How can brands optimize their ad spend while ensuring data neutrality? Data-driven professional Meghan Corroon helps brands assess the effectiveness of their retail media investments. Instead of relying on self-reported metrics from ad platforms — often skewed by conflicts of interest — companies should use third-party measurements to make data-driven decisions. Meghan explains how the halo effect influences buying habits across multiple retailers, emphasizing that retail media approaches must extend beyond just traditional performance metrics. By shifting to a neutral, evidence-based approach, brands can identify high-performing networks and reallocate budgets to maximize returns. Tune in to this episode of The Digital Deep Dive as Aaron Conant hosts Meghan Corroon, the Co-founder and CEO of Clerdata, to discuss the future of retail media measurement. Meghan shares insights on optimizing retail media spend, evaluating ad performance, and navigating the growing complexities of retail media. She also highlights how brands can balance performance marketing with long-term profitability in an increasingly data-driven landscape.

“ A lot of women are living in uncertainty about their health — so most of us are in a really weird situationship with our health. And that to me is quite sad.” Dr. Varuna Srinivasan is the Founder & CEO of Fluid Health — she is a sexual health expert, writer, and speaker based in Brooklyn. For the past decade, Varuna has worked on improving reproductive health access with organizations such as Doctors Without Borders, the Bill & Melinda Gates Foundation, Planned Parenthood, and more. Her work has appeared in the Washington Post, Paper, Health, and Parents, and has been recognized by the NHS, Bumble, and even Serena Williams. Varuna + Fluid Health's mission is to leverage education and technology to provide inclusive and personalized sexual health care. Varuna's actually a “friend of a FrieMMd of the Pod” - first introduced to us by past guest Dr. Nzinga Harrison - Hi Nzinga. You'll enjoy this conversation that follows many cups of chai - chatting work, life entrepreneurship, India, and family. LEARN MORE myfluidhealth.com/ instagram.com/drvarunasrinivasan Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you ready to revolutionize how you approach sales? In this episode, Dr. Lauryn welcomes Nikki Rausch, the Sales Maven herself, to uncover the secrets of creating effortless and authentic sales conversations. Nikki brings nearly three decades of experience, sharing her proven strategies to help you build rapport, ask better questions, and close with confidence. Whether you're a seasoned professional or new to selling, this conversation will inspire you to see sales as a service, not a struggle.Together, they dive into the "Selling Staircase," a five-step process that takes the guesswork out of selling. From syncing communication styles to overcoming objections with ease, Nikki breaks down actionable techniques to help you serve your clients better and grow your business. Tune in for a game-changing perspective on sales that prioritizes connection and value.Key Takeaways:Build Rapport First: Successful sales conversations are rooted in connection. Nikki explains how to establish rapport by syncing communication styles and adjusting behaviors to match your client.Ask Better Questions: Instead of making statements, ask strategic questions to guide clients toward discovering their needs. This creates stronger buy-in and long-term trust.Permission-Based Selling: Always ask for permission before presenting a solution. This step ensures your client is ready to engage and helps avoid feeling pushy or salesy.Master the Selling Staircase: Nikki's five-step framework—Introduction, Create Curiosity, Discovery, Proposal, and Close—offers a simple, effective approach to sales that's easy to implement and drives results.About the Guest:Nikki Rausch is the founder of Sales Maven, a company dedicated to helping entrepreneurs and small business owners master the art of selling. With over 25 years of experience working with organizations like NASA, HP, and The Bill & Melinda Gates Foundation, Nikki brings unparalleled expertise in relationship-driven sales. She's the author of three books, including The Selling Staircase, and hosts the popular podcast Sales Maven. Through her workshops, VIP consultations, and Sales Maven Society, Nikki equips her clients with practical tools to boost confidence and close deals with ease.Follow Nikki: Facebook | Instagram | LinkedInListen to Nikki's podcast, Sales Maven: Apple | SpotifyClosing the Sale ebook for free: https://yoursalesmaven.com/sheslays Resources:Sign up for the Weekly Slay newsletter!Questions? Feedback? Just want to tell Lauryn you love and appreciate her? Get in contact here: Instagram | Website | FacebookSign up here to receive our monthly associate job postings...

This week on Black & Published, Nikesha speaks with Iris Mwanza, author of the novel The Lion's Den. It's a thriller featuring a young lawyer fighting for justice in the case of a queer teen, that has her going up against every oppressive system in Zambia from the President and police to her priest and the doctrine of the Catholic Church. Iris is Zambian-American. She started her career as an attorney, but currently serves as the Deputy Director of the Women in Leadership team at the Bill & Melinda Gates Foundation.In our conversation, she explains why she's more intrigued about exploring what the law could and should be, versus what it actually is. Plus, the newspaper story that's stayed with her for 30 years that inspired her novel. And why she believes authors must write something that matters. Mahogany Books Mentioned in this episode:Rate & ReviewThanks for listening, family! Please do us a solid and take a quick moment to rate and/or leave a review for this podcast. It will go a long way to making sure content featuring our stories and perspectives are seen on this platform

Yet another fictional health simulation was conducted in Brussels, Belgium on October 23, 2022, that simulated a deadly respiratory virus that was unleashed upon the world and disproportionately impacted children. The event was organized by the Johns Hopkins Center for Health Security, the World Health Organization, and the Bill & Melinda Gates Foundation. Again. Just like the other simulations Johns Hopkins has held, this one called for draconian policies to be implemented in the name of “global health”, and for a “Pandemic Corps” to be formed and installed worldwide in order to be ready for the next outbreak. This wasn't the only simulation that happened recently. There was an unusual event that was also quietly held in Europe during the COVID pandemic, but nobody in the media seems to want to talk about it much, for obvious reasons. The Octopus of Global Control Audiobook: https://amzn.to/3xu0rMm Website: www.Macroaggressions.io Sponsors: Chemical Free Body: https://www.chemicalfreebody.com Promo Code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO Christian Yordanov's Health Transformation Program: www.LiveLongerFormula.com Privacy Academy: https://privacyacademy.com/step/privacy-action-plan-checkout-2/?ref=5620 Brain Supreme: www.BrainSupreme.co Promo Code: MACRO Above Phone: http://abovephone.com/?above=macro Promo Code: MACRO Activist Post: www.ActivistPost.com Natural Blaze: www.NaturalBlaze.com Link Tree: https://linktr.ee/macroaggressionspodcast

Can genius and empathy coexist or are we doomed to put up with tortured, erratic leaders to find breakthroughs? People cite examples of temperamental, even bullying, genius leaders who create toxic workplaces and use their ability to unlock innovation as an excuse for their damaging behavior. My guest today, Taryn Voget, debunks this myth, shows us what genius is all about, and how empathy serves as a catalyst for genius.Today we discuss what genius is and why it's not simply about being born with it. Taryn shares the link between genius, spirituality, and empathy - and some unique ways leaders have leveraged empathy to achieve innovative insights. She shares how genius actually works and offers you tips on how to enhance your and your team's genius in the workplace. You will leave today's episode inspired to embrace and cultivate your own genius. To access the episode transcript, please search for the episode title at www.TheEmpathyEdge.comKey Takeaways:Genius is a verb, it is not something you can measure on a test.Effective engagement and genius happen when you try to see things from the other person's point of view and address those goals, fears, needs, expectations, and aspirations.Are you excited as a leader? The energy you bring will be the energy that the team feels. If you're not operating from excitement, how can you expect your team to be?"Genius is activated through excitement, because that is the driving engine that creates continuous improvement, getting better over time." — Taryn Voget Episode References:Big Magic: Creative Living Beyond Fear by Elizabeth GilbertThe Empathy Edge podcast: Denise Roberson: Mistakes Leaders and Boards Make When Thinking About PurposeFrom Our Partner:SparkEffect partners with organizations to unlock the full potential of their greatest asset: their people. Through their tailored assessments and expert coaching at every level, SparkEffect helps organizations manage change, sustain growth, and chart a path to a brighter future.Go to sparkeffect.com/edge now and download your complimentary Professional and Organizational Alignment Review today.About Taryn Voget: Founder, EveryDay GeniusTaryn Voget is a leading expert on genius and the founder of Everyday Genius, a media and education company that unpacks the strategies of genius from the world's top minds. Through her engaging and relatable videos and podcast, Taryn shares these strategies with actionable insights that help people fast-track their growth and unleash their genius.Known for her dynamic talks on genius, innovation, passion, purpose, and business, Taryn inspires audiences to think bigger and aim higher. She's the author of six books on the strategies of genius (plus a memoir!) and works with individuals and organizations to uncover and amplify their unique genius.Taryn's clients include industry giants such as SpaceX, Disney, The Bill & Melinda Gates Foundation, Gap Inc., Genentech, and many more.Connect with Taryn:Everyday Genius: everydaygenius.tvTaryn Voget Consulting: tarynvoget.comX: x.com/tarynvogetLinkedIn: linkedin.com/in/tarynvogetFacebook: facebook.com/tarynvogetInstagram: instagram.com/tarynvogetYouTube: youtube.com/@tarynvoget Connect with Maria:Get the podcast and book: TheEmpathyEdge.comLearn more about Maria and her work: Red-Slice.comHire Maria to speak at your next event: Red-Slice.com/Speaker-Maria-RossTake my LinkedIn Learning Course! Leading with EmpathyLinkedIn: Maria RossInstagram: @redslicemariaX: @redsliceFacebook: Red SliceThreads: @redslicemariaAchieve radical success putting empathy into action with Businessolver. Techlology with heart, powered by people. https://www.businessolver.com/edge

Live from an ESG-flavored 2025, it's an all-new Wacky Wednesday edition of Business Pants. Joined by Analyst-Hole Matt Moscardi! On today's Costco lovefest called January 8th 2025: Headlines We Missed since the end of December and the new comic book superhero named Costco!Our show today is being sponsored by Free Float Analytics, the only platform measuring board power, connections, and performance for FREE.DAMION1Shit We Missed (in no particular order):Tech BrosZuckDana White, UFC CEO and Trump ally, to join Meta's board of directorsZuckerberg Announces New Measures to Increase Hate Speech on FacebookMark Zuckerberg's Meta is moving moderators out of California to combat concerns about bias and censorship“Huge problems” with axing fact-checkers, Meta oversight board saysCo-chair Helle Thorning-Schmidt said she is "very concerned" about how parent company Meta's decision to ditch fact-checkers will affect minority groups: "We are seeing many instances where hate speech can lead to real-life harm, so we will be watching that space very carefully," she added.Meta Drops Rules Protecting LGBTQ Community as Part of Content Moderation OverhaulThe changes included allowing users to share “allegations of mental illness or abnormality when based on gender or sexual orientation, given political and religious discourse about transgenderism and homosexuality.”Meta replaces policy chief Nick Clegg with former Republican staffer Joel Kaplan ahead of Trump inaugurationSamSam Altman Explodes at Board Members Who Fired Him"And all those people that I feel like really fucked me and fucked the company were gone, and now I had to clean up their mess," adding that he was "fucking depressed and tired.""And it felt so unfair," the billionaire told Bloomberg. "It was just a crazy thing to have to go through and then have no time to recover, because the house was on fire."The board's primary fiduciary duty was not to maintain shareholder value or profits, but rather to stay true to OpenAI's mission of creating safe artificial general intelligence (AGI) that benefits humanity.Helen Toner: the director of strategy at Georgetown's Center for Security and Emerging Technology.Tasha McCauley: an adjunct senior management scientist at think tank RAND Corporation. McCauley was also on the advisory board of the Centre for Effective Altruism. In 2017 she signed the Asilomar AI Principles on ethical AI development alongside Altman, OpenAI co-founder Ilya Sutskever, and former board member Elon MuskOpenAI CEO Sam Altman denies sexual abuse allegations made by his sister in lawsuitMuskMaga v Musk: Trump camp divided in bitter fight over immigration policyElon Musk Endorses Nazi-Linked German Party, Even Though It Opposed Tesla's GigafactoryTech Bro Wealth12 US billionaires gained almost $1 trillion in wealth in 2024 as the stock market delivered another year of massive returnsNYT Report Says Jensen Huang, The CEO Of Nvidia And The 10th-Richest Person In The U.S., Trying To Allegedly Avoid $8 Billion In TaxesMark Zuckerberg says he doesn't have a Hawaiian doomsday bunker, just a 'little shelter.' It's bigger than most houses.You could live next door to Jeff Bezos on 'Billionaire Bunker' island for $200 millionMusk urges Bezos to throw an ‘epic wedding' after Amazon founder blasts report of $600 million nuptials as ‘completely false'Elon Musk takes aim at MacKenzie Scott again for giving billions to liberal causes, calling the gifts 'concerning'How Jensen Huang and 3 Nvidia Board Members Became BillionairesMark Zuckerberg sported a $900,000 piece of wrist candy as he announced the end of fact-checking on MetaDEI/ESG Flip-FloppingWhen an anti-DEI activist took a swing at Costco, the board hit backA Costco shareholder proposal brought by conservative activist The National Center for Public Policy Research asked the company to probe its diversity, equity and inclusion policies, with an eye toward eliminating them.The thrust of the proposal is that certain DEI initiatives could open Costco up to financial risks over discrimination lawsuits from employees who are “white, Asian, male or straight.”The company's board of directors unanimously urged shareholders to reject the proposal and made the case that Costco's success depends on establishing a racially diverse, inclusive workplace: “We believe that our diversity, equity and inclusion efforts are legally appropriate, and nothing in the (Center for Public Policy Research) proposal demonstrates otherwise,” the board's statement said.The statement went on to rebuke the Center for Public Policy Research, saying that they and others were the ones responsible for inflicting financial and legal burdens on companies. “The proponent's broader agenda is not reducing the risk for the Company but abolition of diversity programs,” the board said.Costco board member defends DEI practices, rebukes companies scrapping policiesJeff Raikes, co-founder of the Raikes Foundation and former CEO of the Bill & Melinda Gates Foundation, who has served on Costco's board of directors since 2008: "Attacks on DEI aren't just bad for business—they hurt our economy. A diverse workforce drives innovation, expands markets, and fuels growth. Let's focus on building a future where all talent thrives." He concluded his post on X with the hashtag, "InclusiveEconomy." While businesses began to announce their departures from DEI policies last year, Raikes urged companies to expand such practices at work, insisting that scaling down DEI in businesses would harm the economy.Robbie Starbuck: “I fully endorse cancelling memberships at this point.”McDonald's rolls back DEI programs, ending push for greater diversityFour years after launching a push for more diversity in its ranks,McDonald's said it will retire specific goals for achieving diversity at senior leadership levels. It also intends to end a program that encourages its suppliers to develop diversity training and to increase the number of minority group members represented within their own leadership ranks.Managers 'touch up' staff: McDonald's faces fresh abuse claimsFast-food chain McDonald's has been hit by fresh allegations of sexual and homophobic abuse as staff members allege they have been 'touched up' by managers and offered extra shifts for sex.The chain first faced bombshell claims of widespread sexual abuse and harassment at its stores in July 2023 and has since been reported more than 300 times for harassment to the UK's equality watchdog.Allegations have included racist abuse, sexual assault and harassment and bullying. BlackRock Cuts Back on Board Diversity Push in Proxy-Vote GuidelinesThe policy updates remove both (a) numerical diversity targets (i.e., boards should aspire to 30% diversity of membership and have at least 2 women directors and 1 director from an underrepresented group) and (b) the related disclosure-based voting policy (i.e., BlackRock previously would consider taking voting action if a company did not adequately explain its approach to board diversity) – but provides that BlackRock may consider taking voting action if an S&P 500 board is not sufficiently diverse (BlackRock includes a footnote in the policy update suggesting that 30% diversity may still be the expectation).BlackRock's investment stewardship team tweaked the language used to describe how it approaches votes for other companies' boards. It didn't explicitly recommend that boards should aspire to at least 30% diversity of their members, after having done so in previous years.The report noted, however, that all but 2% of the boards of companies in the S&P 500 have diverse representation of at least 30%—and that if companies were out of step with those norms, BlackRock may cast opposing votes on a case-by-case basis. JPMorgan Leaves Net Zero Banking Group, Completing Departure of Major U.S. Banks Stakeholder Anger (or Anger at Stakeholders)Poll finds many Americans pin partial blame on insurance companies in UHC CEO killingA recent survey from the University of Chicago, found that, while 8 out of 10 U.S. adults believe the person who killed Brian Thompson bears the responsibility for the murder, 7 in 10 shared the belief that healthcare companies are also to blame. Luigi Mangione mention on SNL met with applause, critics slam 'woke' audience: 'Wooing for justice?'New York to charge fossil fuel companies for damage from climate changeThe new law requires companies responsible for substantial greenhouse gas emissions to pay into a state fund for infrastructure projects meant to repair or avoid future damage from climate change.Albania bans TikTok for a year after fatal stabbing of teenager last monthTeens in Vietnam will now be limited to one hour of gaming per sessionStarbucks baristas set to strike as new CEO makes $100 millionWashington Post Cartoonist Quits After Jeff Bezos Cartoon Is KilledNorway on track to be the first to ‘erase petrol and diesel engine cars'Fully electric vehicles accounted for 88.9% of new cars sold in 2024Exxon Sues California Official, Claiming He Defamed the CompanyExxon Mobil sued California's attorney general, the Sierra Club and other environmental groups on Monday, alleging that they conspired to defame the oil giant and kneecap its business prospects amid a debate over whether plastics can be recycled effectively.DystopiaMan Trying to Catch Flight Alarmed as His Driverless Waymo Gets Stuck Driving in Loop Around Parking LotAsked to Write a Screenplay, ChatGPT Started Procrastinating and Making ExcusesKlarna's CEO says AI is capable of doing his job and it makes him feel 'gloomy'Governance newsShari Redstone is saying goodbye to Paramount GlobalCharles Dolan, TV pioneer who founded HBO and Cablevision, dies at 98Richard Parsons, former Time Warner CEO, dies at age 76 Dye & Durham board resigns, activist nominees take control, interim CEO named The Fortune 500 has two new female CEOs—finally pushing that milestone above 11%And we end with a few classics:Boeing ends a troubled year with a jet-crash disaster in South KoreaMan who exploded Tesla Cybertruck outside Trump hotel used ChatGPT to plan the attackNorovirus rates have skyrocketed by 340% this season. Here's where the ‘winter vomiting disease' is spreading and whyMATT1CostcoNational Center for Public Policy Research filed the proxy with CostcoTheir arguments include…US Supreme court decision at HarvardA $25m judgment in PA for white regional manager at Starbucks who was fired after two black patrons were arrested for being blackThis gem: “With 310,000 employees, Costco likely has at least 200,000 employees who are potentially victims of this type of illegal discrimination because they are white, Asian, male or straight.”This, perhaps, is the greatest ironic argument for “meritocracy” ever made in historyThey point out that the MAJORITY OF THE STAFF is white, Asian, male, or straight… but they don't even use Costco's data, they source census data and just guessThe real numbers:Non management is 44.2% white, management is 58% white - a 14% increase in meritocracyExecutives are 80.6% white - a whopping 36.4% more meritHispanics are 33.1% of non management, 23.3% of management - 9.8% less merit!Executives are 5.8% Hispanic, 26.3% less meritAsians are 8.5% and 7.1%, so 1.4% less merit7.9% executive - so even merit?US Exec management is 72.3% maleSo 80.6% of executives are white, and 72.3% are male - and the argument NCPPR is making is that BECAUSE there are a lot of white males, there is a lot of RISK that THE WHITE MALES WILL SUE YOU if they think they're discriminated againstThink of what they're saying - because you have so many non diverse people, you can't have diversity programs for risk of lawsuitThe response dropped the pretense that the proxy was anything except racismThe proponent professes concern about legal and financial risks to the Company and its shareholders associated with the diversity initiatives. The proponent's broader agenda is not reducing risk for the Company but abolition of diversity initiatives. A 2023 federal district court decision, in a case brought by the proponent, noted that the proponent had "published a document called 'Balancing the Boardroom 2022,' which describes its shareholder activism as 'fighting back' against 'the evils of woke politicized capital and companies.' [The proponent went] on to describe 'CEOs and other corporate executives who are most woke and most hard-left political in their management of their corporations' as 'inimical to the Republic and its blessings of liberty' and 'committed to critical race theory and the socialist foundations of woke' or 'shameless monsters who are willing to sacrifice our future for their comforts.'" National Center for Public Policy Research v. Schultz, E.D. WA. (Sept. 11, 2023). And the proponent's efforts to demonstrate retrenchment on the part of companies are misleading, at best. For example, the assertion that "Microsoft laid off an entirea[sic] DEI team" is simply wrong. It was later reported that Microsoft stated that the two positions eliminated were redundant roles on its events team and that Microsoft's diversity and inclusion commitments remain unchanged, according to Jeff Jones, a Microsoft spokesperson: “Our focus on diversity and inclusion is unwavering and we are holding firm on our expectations, prioritizing accountability, and continuing to focus on this work.” Colvin, Caroline. Amid DEI cuts, Microsoft works to distinguish itself from those responding to ‘woke' backlash. HR Dive, July 24, 2024.Reason Costco might be pushing back?Racism is basically unveiledOf all the companies targeted by a proposal or Robbie Starbuck, Costco has the lowest deviation in board member influence - as in, nearly the entire board has equal power, it's highly democratic - women, men, diverse cohorts are more or less equally powerful to anyone else in the roomNo connections to any board member on another DEI flipper companyMeanwhile, the anti DEI, anti immigrant movement has begun to eat itself before Trump even takes officeIn defense of more HB1 visas and foreign workers, Vivek Ramaswamy says we venerate jocks over valedictorians on Twitter, and Americans aren't as good employeesThe rebuttal was MAGA Trumpers saying Vivek is fake MAGAAlso this: “His entire argument is a terrible proposition,” he adds. “Children raised to be good little robots might grow up to build robots of their own someday, and become rich. Asians are the highest-earning racial group in America, but are they happier for it? Suicide is the leading cause of death for Asians aged 15-24 … and the second-leading cause of death for those aged 25-34.” Page points to a Psychology Today post that blames tiger parenting for causing anxiety and depression and then asks, “Do we really want this country to be even more stressed-out?”Costco proxy says Asians are discriminated againstTwitch gamers are streaming about “meritocracy”

All in 24 Minutes or less… In Season 5, Episode 33, Travis sits down with Kelley Haggert, Chief Marketing Officer at FC Cincinnati of the MLS. Kelley has worked in a variety of other industries like Walt Disney and Bill and Melinda Gates Foundation to name a few. Tune in to hear her advice on how to be successful regardless of the industry or role. 3 Hot Topics: ✅ Willing to Take a Risk    ✅ Key Characteristic in Successful People    ✅ Similarities and Differences in Other Industries  www.52weeksofhustle.com Book Available - https://www.amazon.com/dp/1735610801 Learn more about your ad choices. Visit podcastchoices.com/adchoices

The scandal surrounding Bill Gates and his relationship with Jeffrey Epstein primarily revolves around their meetings and associations, which have come under scrutiny due to Epstein's criminal activities and notorious reputation.Key Points of the Scandal:Initial Connections: Bill Gates, co-founder of Microsoft and a prominent philanthropist, first met Jeffrey Epstein in 2011, several years after Epstein had been convicted of sex crimes involving minors. Gates has claimed that he met with Epstein to discuss philanthropy, as Epstein was well-connected with wealthy individuals who could potentially contribute to global health initiatives supported by the Bill and Melinda Gates Foundation.Frequency of Meetings: Reports have surfaced that Gates met with Epstein on multiple occasions, including at Epstein's Manhattan townhouse. These meetings, which continued into the mid-2010s, have raised questions about why Gates, given his stature and resources, would associate with someone of Epstein's notoriety, especially after Epstein's criminal conviction.Public and Media Scrutiny: The relationship between Gates and Epstein became widely known after Epstein's arrest in 2019 and subsequent death in jail under suspicious circumstances. The media and the public have scrutinized Gates for these connections, particularly in light of Epstein's involvement in sex trafficking.Gates' Response: Gates has expressed regret for meeting with Epstein, calling it "a mistake." He has emphasized that their interactions were strictly business-related and focused on philanthropic endeavors. However, critics have questioned the wisdom of engaging with Epstein at all, considering his criminal past.Impact on Gates' Reputation: The revelations about Gates' meetings with Epstein have somewhat tarnished his public image, especially given his role as a global philanthropist. This controversy has added to the public discourse on how powerful individuals interact with those involved in criminal activities and whether such associations are ever justified.(commercial at 14:29)to contact me:bobbycapucci@protonmail.comsource:Bill Gates believed Jeffrey Epstein could deliver the Nobel Prize he craved. Instead, their toxic dalliance destroyed Gates' marriage and stained his 'saintly' reputation for ever... as revealed in a new book about billionaire Microsoft founder | Daily Mail OnlineBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

At the heart of The Prophets' vision are “The 24 Essential Supply Chain Processes.” What are they? Find out, and see the future yourself. Click here Is your organization ready to thrive in a world of constant disruption? Dr. Nadya Zhexembayeva, Chief Reinvention Officer and founder of the Reinvention Academy joins Terry Onica and Jan Griffiths on Auto Supply Chain Prophets to explore why reinvention has become the top priority for businesses worldwide.The days of long business cycles are over. Today, the average lifespan of a business model is down to just five years. With change accelerating across industries, companies can no longer rely on incremental improvements—they must embrace reinvention as an ongoing, proactive process.But what does reinvention look like? From Philips' shift from consumer electronics to medical imaging to how a Slovenian heating company found its future in the automotive sector, Dr. Nadya's real-world examples reveal how rethinking strengths and opportunities can open new doors.She also introduces The Titanic Syndrome, her groundbreaking book that draws a parallel between the Titanic's fate and the challenges modern businesses face. With striking examples—from Kodak's demise to startling statistics about Fortune 500 turnover—Dr. Nadya challenges leaders to rethink their approach before their organizations hit their own iceberg.The real challenge? Culture. To address this, Dr. Nadya offers practical advice for leaders: gather your team for a "75-5 Exercise" that encourages them to rethink long-held assumptions and establish new rules for thriving in today's fast-paced world.Dr. Nadya's message is clear: Stability is gone, and disruption is here to stay. Leaders must adjust their mindsets and embrace reinvention as a continuous journey. By doing so, they can turn challenges into opportunities and ensure their organizations not only survive but thrive.Themes discussed in this episode:The rapid decline in business model lifespans, from decades to just five years, and what this means for the industryWhy incremental changes are no longer enough in today's fast-paced worldHow Philips' pivot to medical imaging and Hidria's transition to automotive demonstrate the power of rethinking strengthsThe concept of The Titanic Syndrome and how overconfidence, resistance to change, and lost knowledge are leading businesses to failureThe cultural transformation needed to embrace continuous reinvention across teams and leadershipPractical tools like the “75-5 Exercise” to challenge old assumptions and create new strategies for today's evolving marketWhy leaders must see disruption as the new normal and treat reinvention as an ongoing, proactive processFeatured on this episode: Name: Dr. Nadya ZhexembayevaTitle: Founder & Chief Reinvention Officer, Reinvention AcademyAbout: Known as “The Reinvention Guru” and “The Queen of Reinvention,” Dr. Nadya Zhexembayeva is a scientist, entrepreneur, and acclaimed author with expertise in resilience and reinvention. She has guided organizations like the Bill & Melinda Gates Foundation, Coca-Cola, Cisco, L'Oréal, Danone, Henkel, Erste Bank, Danfoss, and Knauf Insulation in transforming their products, leadership strategies, and business models to adapt to shifting market demands and anticipate future disruptions. Nadya has delivered keynotes and workshops to over 500,000 executives, including four TEDx talks. Her award-winning books, along with her contributions to Forbes and Harvard Business Review, further solidify her as a thought leader in

We are delighted to host Simeon Schnapper on the Mangu.tv podcast series.  Simeon's passion and expertise span over 30 years in the fields of research, philanthropy advocacy, policy, and criminal justice reform in the science of psychedelics. He provides valuable guidance to various organisations including nonprofit, psychedelic and impact start-ups, family offices as of states and several newly formed governments. He co-founded the GLS fund, groundbreaking venture capital in this field, and spearheaded the world's inaugural psychedelic investment summit at the start of the decade. Recipient of the MacArthur Foundation, and the Bill and Melinda Gates Foundation, he's an Aspen Institute fellow. While embracing a global outlook of impact and when not living on aeroplanes, visiting portfolio companies, he spends his time between Manhattan, Montenegro and Western Central Africa.  Simeon speaks about his upbringing, his parent's work with Peacecore, his childhood in Western Samoa, and later in Chicago. He talks about his teen years, his curiosity in spiritual practices and altered states, as well as his time in Ghana. Simeon discusses his role in opening the first psychedelic art gallery and medical marijuana dispensary in California, and subsequent involvement in alternative medicine, as well as investing in philanthropic and holistic endeavours.  Giancarlo and Simeon discuss the medicalisation of Psychedelics such as Psylocibiin and MDMA as well as the complexities of their use in a Western medicinal context, ways to manage approved drug use to minimalise their abuse as well as informing the global perspective on Psychedelics as medicine.

Dr. Kevin Roberts joins Joshua Treviño of the Texas Public Policy Foundation to discuss his new book, Dawn's Early Light: Taking Back Washington to Save America. He outlines a plan to challenge the Washington establishment and shares personal insights from his journey. AN INSTANT NATIONAL BESTSELLER WITH A FOREWORD BY VICE PRESIDENT-ELECT J.D. VANCE Heritage Foundation president Kevin Roberts outlines a peaceful "Second American Revolution" for voters looking to shift the power back into the hands of the people. America is on the brink of destruction. A corrupt and incompetent elite has uprooted our way of life and is brainwashing the next generation. Many so-called conservatives are as culpable as their progressive counterparts. In this ambitious and provocative book, Heritage Foundation President Dr. Kevin Roberts announces the arrival of a New Conservative Movement. His message is simple: Global elites — your time is up. Dawn's Early Light blazes a promising path for the American people to take back their country. Chapter by chapter, it identifies institutions that conservatives need to build, others that we need to take back, and more still that are too corrupt to save: Ivy League colleges, the FBI, the New York Times, the National Institute of Allergy and Infectious Diseases, the Department of Education, BlackRock, the Bill and Melinda Gates Foundation, the National Endowment for Democracy, to name a few. All these need to be dissolved if the American way of life is to be passed down to future generations. The good news is, we're going to win. The Swamp is so drunk on power that the elites don't realize the ground is moving beneath their feet. In Washington, they wear foreign flags on their lapels, but they don't protect our border. They wave around the Constitution, but they don't respect its wisdom. They appeal to Reagan, but Reagan would never put up with this non-sense. Their decadence will be their downfall. A new day is here.

In this milestone episode of the Positive Leadership Podcast, I'm joined by someone who has had a profound influence on my career and personal growth—Jeff Raikes. Jeff and I share a deep connection, having both spent significant time at Microsoft, where he became a legendary manager and mentor to me.From his early days at Microsoft in 1981 to his pivotal role as President of the Business Division, Jeff's leadership has been integral to the company's success. Beyond his Microsoft career, Jeff is known for his extraordinary philanthropic work. As the former CEO of the Bill & Melinda Gates Foundation and co-founder of the Raikes Foundation with his wife Tricia, he has made a lasting impact in youth development, education, and addressing youth homelessness.In today's conversation, we dive into the principles of leadership that have guided Jeff throughout his career and explore how his commitment to making the world a better place continues to drive his work.Tune in for an insightful discussion on leadership, giving back, and the power of making a lasting difference.Interested in other similar episodes with great positive leaders?Don't miss my conversation with Yoshito Hori, founder of GLOBIS Corporation, GLOBIS University, and GLOBIS Capital Partners: https://thepositiveleadershippodcast.buzzsprout.com/1798971/episodes/16010088-combining-purpose-and-entrepreneurship-for-japan-s-future-with-yoshito-horiOr with Kevin Scott, Microsoft's chief technology officer: https://thepositiveleadershippodcast.buzzsprout.com/1798971/episodes/14764673-empowering-people-with-ai-with-kevin-scottSubscribe now to JP's free monthly newsletter "Positive Leadership and You" on LinkedIn to transform your positive impact today: https://www.linkedin.com/newsletters/positive-leadership-you-6970390170017669121/

In the episode, we are joined by Regine Webster. Regine is a philanthropic consultant, guiding foundations to create sustainable and equitable impact. She was the founding executive director and vice president of the Center for Disaster Philanthropy, an organization aimed at transforming disaster-related giving worldwide. A trusted voice in the sector, Regine has worked to develop the field of disaster philanthropy over the past twenty years. Regine is one of only a handful of people nationwide who have managed a dedicated disaster portfolio for a foundation; including the Center for Disaster Philanthropy, she has worked with the Bill & Melinda Gates Foundation, the Conrad N. Hilton Foundation, and Arabella Advisors. In this episode, we discuss: What disaster philanthropy means and the intersectional nature of disasters How philanthropy can provide support for disaster-related challenges The role technology plays in identifying need and targeting response surrounding disasters

In the sixth episode of the CommonHealth Live! series, Katherine E. Bliss will sit down with Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean. Dr. Balkhy will speak to her evolving vision for the region, encompassing EMRO's multiple complex humanitarian operations—in Gaza, Yemen, Afghanistan, Libya, and beyond. She will also reflect on the growing challenge of antimicrobial resistance and what may come out of the UN High-Level Meeting on Antimicrobial Resistance (AMR) to be held on the margins of the UN General Assembly on September 26. This event is made possible through the generous support of the Bill & Melinda Gates Foundation. 

Jeremy Forman joins us to open up about the hurdles– and successes that come with building data products for pharmaceutical companies. Although he's new to Pfizer, Jeremy has years of experience leading data teams at organizations like Seagen and the Bill and Melinda Gates Foundation. He currently serves in a more specialized role in Pfizer's R&D department, building AI and analytical data products for scientists and researchers. .     Jeremy gave us a good luck at his team makeup, and in particular, how his data product analysts and UX designers work with pharmaceutical scientists and domain experts to build data-driven solutions..  We talked a good deal about how and when UX design plays a role in Pfizer's data products, including a GenAI-based application they recently launched internally.       Highlights/ Skip to: (1:26) Jeremy's background in analytics and transition into working for Pfizer (2:42) Building an effective AI analytics and data team for pharma R&D (5:20) How Pfizer finds data products managers (8:03) Jeremy's philosophy behind building data products and how he adapts it to Pfizer (12:32) The moment Jeremy heard a Pfizer end-user use product management research language and why it mattered (13:55) How Jeremy's technical team members work with UX designers (18:00) The challenges that come with producing data products in the medical field (23:02) How to justify spending the budget on UX design for data products (24:59) The results we've seen having UX design work on AI / GenAI products (25:53) What Jeremy learned at the  Bill & Melinda Gates Foundation with regards to UX and its impact on him now (28:22) Managing the "rough dance" between data science and UX (33:22) Breaking down Jeremy's GenAI application demo from CDIOQ (36:02) What would Jeremy prioritize right now if his team got additional funding (38:48) Advice Jeremy would have given himself 10 years ago (40:46) Where you can find more from Jeremy     Quotes from Today's Episode “We have stream-aligned squads focused on specific areas such as regulatory, safety and quality, or oncology research. That's so we can create functional career pathing and limit context switching and fragmentation. They can become experts in their particular area and build a culture within that small team. It's difficult to build good [pharma] data products. You need to understand the domain you're supporting. You can't take somebody with a financial background and put them in an Omics situation. It just doesn't work. And we have a lot of the scars, and the failures to prove that.” - Jeremy Forman (4:12) “You have to have the product mindset to deliver the value and the promise of AI data analytics. I think small, independent, autonomous, empowered squads with a product leader is the only way that you can iterate fast enough with [pharma data products].” - Jeremy Forman (8:46) “The biggest challenge is when we say data products. It means a lot of different things to a lot of different people, and it's difficult to articulate what a data product is. Is it a view in a database? Is it a table? Is it a query? We're all talking about it in different terms, and nobody's actually delivering data products.” - Jeremy Forman (10:53) “I think when we're talking about [data products] there's some type of data asset that has value to an end-user, versus a report or an algorithm. I think it's even hard for UX people to really understand how to think about an actual data product. I think it's hard for people to conceptualize, how do we do design around that? It's one of the areas I think I've seen the biggest challenges, and I think some of the areas we've learned the most. If you build a data product, it's not accurate, and people are getting results that are incomplete… people will abandon it quickly.” - Jeremy Forman (15:56) “ I think that UX design and AI development or data science work is a magical partnership, but they often don't know how to work with each other. That's been a challenge, but I think investing in that has been critical to us. Even though we've had struggles… I think we've also done a good job of understanding the [user] experience and impact that we want to have. The prototype we shared [at CDIOQ] is driven by user experience and trying to get information in the hands of the research organization to understand some portfolio types of decisions that have been made in the past. And it's been really successful.” - Jeremy Forman (24:59) “If you're having technology conversations with your business users, and you're focused only the technology output, you're just building reports. [After adopting If we're having technology conversations with our business users and only focused on the technology output, we're just building reports. [After we adopted  a human-centered design approach], it was talking [with end-users] about outcomes, value, and adoption. Having that resource transformed the conversation, and I felt like our quality went up. I felt like our output went down, but our impact went up. [End-users] loved the tools, and that wasn't what was happening before… I credit a lot of that to the human-centered design team.” - Jeremy Forman (26:39) “When you're thinking about automation through machine learning or building algorithms for [clinical trial analysis], it becomes a harder dance between data scientists and human-centered design. I think there's a lack of appreciation and understanding of what UX can do. Human-centered design is an empathy-driven understanding of users' experience, their work, their workflow, and the challenges they have. I don't think there's an appreciation of that skill set.” - Jeremy Forman (29:20) “Are people excited about it? Is there value? Are we hearing positive things? Do they want us to continue? That's really how I've been judging success. Is it saving people time, and do they want to continue to use it? They want to continue to invest in it. They want to take their time as end-users, to help with testing, helping to refine it. Those are the indicators. We're not generating revenue, so what does the adoption look like? Are people excited about it? Are they telling friends? Do they want more? When I hear that the ten people [who were initial users] are happy and that they think it should be rolled out to the whole broader audience, I think that's a good sign.” - Jeremy Forman (35:19)   Links Referenced LinkedIn: https://www.linkedin.com/in/jeremy-forman-6b982710/

Are you a non-profit leader trying to foster a better relationship with funders? Or a donor looking to make a bigger impact with your money? In this episode, Jennifer Alcorn tells us how to navigate and improve the donor-beneficiary relationship based on her experience as the Deputy Director of the Bill and Melinda Gates Foundation. To learn more about the Bill and Melinda Gates Foundation, visit gatesfoundation.org--If you aspire to be a System Catalyst and need resources to help you on your journey, subscribe to our newsletter. To learn more about our mission and our partners, visit systemcatalysts.com.Subscribe to our YouTube channel This podcast is produced by Hueman Group Media. Hosted on Acast. See acast.com/privacy for more information.

As Americans contemplate the implications of a consequential general election, this may be a good time to reflect on the state of the American dream. It is still a powerful idea. And it faces challenges — some are old and intractable, others are novel if not surprising. Allan Golston, president of the U.S. Program for the Bill and Melinda Gates Foundation, joined the podcast to explore the intersection of economic mobility and the American dream. He emphasized the need for equitable access to education and jobs, streamlined government support systems, and the transformative potential of generative AI in addressing resource constraints across U.S. communities. SHOW NOTES Here are the top five takeaways from this episode: Influence of Personal History: Golston's upbringing in a middle-class family, supported by education and hard work, deeply shaped his values. His mother's resilience and dedication to his education influenced his career focus on supporting opportunities for others to achieve economic mobility. Challenges to the American Dream: Golston highlighted declining economic mobility, citing a significant drop from 90 percent of 1940s-born children earning more than their parents to only 50 percent of 1980s-born children. This shift underscores the importance of equitable access to education and job opportunities to keep the American dream alive. Education and Job Market Systems as Key to Mobility: At the Gates Foundation, Golston focuses on strengthening U.S. education and job markets. He advocates for streamlined public education systems, including high-quality early learning, literacy, and post-secondary opportunities. Additionally, simplifying access to safety net benefits is crucial for those encountering life's unexpected setbacks. Solutions-Based Innovations in Government Services: Golston shared examples, such as Michigan's simplified benefits application, that reduce red tape, making essential support accessible. Similarly, initiatives like Results for America's Economic Mobility Catalog promote evidence-based programs to help local governments implement proven solutions for issues like food insecurity and housing. Generative AI's Potential for Equitable Education: Golston sees generative AI as transformative for education, reducing teacher workload by automating grading and making timely feedback accessible. However, he emphasizes that AI resources must be equitable across communities, and biases must be addressed to maximize AI's positive impact on economic mobility and educational equity. Related Link to resources referenced in the episode: Results for America's Economic Mobility Catalog, developed with the support of the Gates Foundation. Our editors used ChatGPT 4.0 to summarize the episode in bullet form to help create the show notes. The main image for this story was created using DALL-E 3.

Welcome to this eye-opening episode of Right on Radio, where we delve deep into the controversial life and legacy of Bill Gates. This episode seeks to uncover the truth behind the man often hailed as a tech genius and philanthropist, exploring the lesser-known aspects of his rise to power and influence. Join us as we examine Gates' journey from a privileged background to becoming the face of Microsoft, and the strategic maneuvers that shaped his empire. We also investigate the controversies surrounding the Bill and Melinda Gates Foundation and its global impact, raising questions about ethics, philanthropy, and power. Discover the untold stories and critical insights, including allegations of unethical practices in vaccine trials and Gates' connections with Jeffrey Epstein. This episode challenges you to think critically about the narratives surrounding one of the most powerful figures in the world today. Thank you for Listening to Right on Radio. Prayerfully consider supporting Right on Radio. Click Here for all links, Right on Community ROC, Podcast web links, Freebies, Products (healing mushrooms, EMP Protection) Social media, courses and more... https://linktr.ee/RightonRadio Live Right in the Real World! We talk God and Politics, Faith Based Broadcast News, views, Opinions and Attitudes We are Your News Now. Keep the Faith

Cordell Carter, Esq. Convenor | Leaders, Ideas, and Experiences Cordell Carter, Esq. is a dynamic leader, speaker, and advisor known for his relentless pursuit of a world where everyone belongs and has opportunities to thrive. As the long-term executive director of the Aspen Institute Socrates Program (2017-2024) and founding director of the Project on Belonging, Cordell curates transformative, off-the-record leadership seminars in capital cities across the globe, shaping the perspectives of over 1,500 leaders annually.   Cordell's passion for creating inclusive spaces led him to establish the Festival of the Diaspora in Medellín, Colombia—a powerful summit (deemed the secular tent revival) uniting diasporic communities across the Americas. As the founder of Expectant Advisory, LLC, he helps leaders and boards navigate their inclusion and belonging journeys with thoughtful strategy and foresight. His leadership journey spans prestigious roles at the Bill and Melinda Gates Foundation, IBM, Seattle Public Schools, and the National Alliance for Public Charter Schools. He is a sought-after speaker and facilitator on belonging, inclusion, post-secondary success, and the democratic ideals that hold our society together. Cordell is also the author of the groundbreaking keynote series, "Becoming an Inclusive Republic," a forthcoming book of the same name, and the producer of the documentary “The Road Trip to Belonging." In recognition of his expertise and leadership, Cordell was appointed by President Biden to the President's Commission on White House Fellowships and has received numerous accolades, including being named a 2023 Minority Executive Making Moves, a 2021 Champion of Change for Computer Science Education, and a distinguished Eisenhower Fellow to China. Cordell also serves as a Board Director for Concordia, Orbit Capital, Oasis Fresh Markets, Redemption Holdings, and the International Advisory Committee of Danubius University (Galatz, Romania). Finally, he is a limited partner with the Fvlcrum Fund and Mendoza Ventures. His influence stretches far and wide. He has spoken in 15 countries and 20 U.S. states on topics such as liberal democracy, belonging, and civic faith. Cordell's leadership extends to corporate boardrooms, advising companies like SkillStorm in their mission to upskill underserved communities. He holds degrees from the University of Notre Dame, Carnegie Mellon University, and the University of Washington, and his thought leadership continues to shape the national and global conversation around equity, inclusion, and the future of democracy. https://CordellCarter.com  

Barry F. Malkin is the Chief Executive Officer of Carnegie Learning. An active operator, investor, and advisor to the educational services sector for over 25 years, Barry took on the role of CEO in 2015. Prior to Carnegie Learning, he was Head of Corporate Development and Strategy at Apollo Education Group, leading corporate development and strategy for one of the world's largest educational services companies.Carnegie Learning is the world's leading edtech company using research and AI to dramatically improve learning outcomes for students. A pioneer in K-12 education for 26+ years, we provide award-winning math, literacy, world languages, professional learning, and high-dosage tutoring solutions to more than 5.5 million students and educators in all 50 states and Canada. Born out of Carnegie Mellon University, our company continues to conduct research with more than $90M in grant funding from the Bill & Melinda Gates Foundation, Walton Family Foundation, and U.S. Department of Education, among others.Links:https://www.carnegielearning.com/blog/interview-with-ceo-barry-malkin/https://www.edsurge.com/news/2017-03-28-living-breathing-and-eating-math-an-interview-with-carnegie-learning-s-barry-malkinhttps://marketscale.com/industries/education-technology/to-improve-student-outcomes-teach-the-why-behind-every-subject/https://www.glassdoor.com/Overview/Working-at-Carnegie-Learning-EI_IE111117.11,28.htmhttps://www.glassdoor.com/Reviews/Carnegie-Learning-Reviews-E111117.htmhttps://www.comparably.com/companies/carnegie-learning/questionshttps://www.comparably.com/companies/carnegie-learning/questions/2102911/what-s-the-interview-process-like-at-carnegie-learninghttps://www.linkedin.com/posts/barrymalkin_longlivelearning-activity-7042261812364410880-5tq3 Hosted on Acast. See acast.com/privacy for more information.

Pivot is off for the holiday! In the meantime, we're bringing you an episode of On With Kara Swisher. Kara is chatting with Bill Gates, the co-founder and former CEO of Microsoft, and the co-chair of the Bill and Melinda Gates Foundation. Bill has been one of the richest people in the world for decades, and he's also spent decades giving away his fortune and working on some of humanity''s most vexing challenges. That's the focus of his Netflix docuseries What's Next? The Future with Bill Gates, where he dives into AI, misinformation, global warming, inequality, and disease. Kara pushes him on the issues, his proposed solutions, and the always tricky details — plus, she finds out who Bill wants to win the presidential election.  This interview was recorded in front of a live audience in New York City. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Bill Gates needs no introduction. The co-founder and former CEO of Microsoft and the co-chair of the Bill and Melinda Gates Foundation has been one of the richest people in the world for decades. He's also spent decades giving away his fortune and working on some of humanity''s most vexing challenges. That's the focus of his Netflix docuseries What's Next? The Future with Bill Gates, where Bill dives into AI, misinformation, global warming, inequality, and disease. Kara interviews Bill in front of a live audience at New York City and pushes him on the issues, his proposed solutions, and the always tricky details — plus, she finds out who Bill wants to win the presidential election.  Questions? Comments? Email us at on@voxmedia.com or find Kara on Threads/Instagram @karaswisher Learn more about your ad choices. Visit podcastchoices.com/adchoices

Every year, the Bill and Melinda Gates Foundation updates progress on the United Nations’ Sustainable Development Goals — how the world is doing on lifting people from poverty, ensuring gender equality, and improving health, sanitation and more. Today, we’re joined by Bill Gates to hear about stalling progress on public health initiatives, as well as opportunities for greater investment. Plus, what we can expect from the Federal Reserve tomorrow?

Every year, the Bill and Melinda Gates Foundation updates progress on the United Nations’ Sustainable Development Goals — how the world is doing on lifting people from poverty, ensuring gender equality, and improving health, sanitation and more. Today, we’re joined by Bill Gates to hear about stalling progress on public health initiatives, as well as opportunities for greater investment. Plus, what we can expect from the Federal Reserve tomorrow?

Bill Gates has told the BBC that governments need to do more to help those living in extreme poverty. Since the pandemic many have cut their aid budgets. A report from the Bill and Melinda Gates Foundation warns that 40 million additional children will suffer from hunger in the coming years because of climate change and a drop in aid in Africa from nearly 40% of the global total in 2010 to just 25%.Elsewhere, Thailand's new Prime Minister Paetongtarn Shinawatra has announced a $13.5 billion cash handout programme for low-income earners and vulnerable groups that will start next week, and will hopefully give the economy a boost. And twenty-four hour party people. How will Montreal's economy benefit from extending their drinking hours?

Dr. Rajiv Shah has worked tirelessly to improve the world. He is the President of The Rockefeller Foundation and has an impressive history of leadership and innovation in global development. His previous work includes leadership roles at USAID, the Bill & Melinda Gates Foundation, and the U.S. Department of Agriculture. He's also the author of the new book, Big Bets: How Large-Scale Change Really Happens, which is available wherever books are sold. On this classic episode, Rajiv joined host Robert Glazer on the Elevate Podcast to discuss his leadership career, how audacious thinking can improve humanity, and much more. Learn more about your ad choices. Visit megaphone.fm/adchoices